Upload longhealthmem ablation: retrieval_reasoning [logs/llm_outputs files 4/4]

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ba3aa2a6e14fdafd.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_ba3aa2a6e14fdafd",
+  "timestamp": "2026-04-10T06:58:46.137273+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which antibiotic therapy was Mr. Carter on that was escalated to Meropenem on 10/05/2021?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"antibiotic therapy\", \"Meropenem\"],\n  \"persons\": [\"Mr. Carter\"],\n  \"time_expression\": \"10/05/2021\",\n  \"location\": null,\n  \"entities\": [\"Meropenem\"]\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"antibiotic therapy\", \"Meropenem\"],\n  \"persons\": [\"Mr. Carter\"],\n  \"time_expression\": \"10/05/2021\",\n  \"location\": null,\n  \"entities\": [\"Meropenem\"]\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804322,
+      "id": "chatcmpl-54e2e55d-cb51-9191-8041-136c137a9cb5",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 62,
+        "prompt_tokens": 199,
+        "total_tokens": 261
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ba96501e9584ed9e.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_ba96501e9584ed9e",
+  "timestamp": "2026-04-10T07:03:49.331957+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_02",
+    "question_id": 0,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mutation analysis for Mrs. Jane Done showed BRAF status mutated, PD-L1 tumor proportion score less than 1%, immune cell infiltrate 2% of tumor area, and PD-L1 combined-positive score 2.\nPersons: Jane Done\nTopic: Molecular biomarker test results\n\n[Context 2]\nContent: As of 2020-10-03, Mrs. Jane Done remained on combination immunotherapy with Nivolumab and Ipilimumab, demonstrated positive response with no new metastatic sites, and showed excellent compliance with treatment and follow-up.\nTime: 2020-10-03T00:00:00\nPersons: Mrs. Jane Done\nRelated Entities: Nivolumab, Ipilimumab\nTopic: Oncology treatment status and response\n\n[Context 3]\nContent: Mrs. Jane Done was prescribed Pembrolizumab 200mg intravenously every 3 weeks.\nPersons: Mrs. Jane Done\nRelated Entities: Pembrolizumab\nTopic: Medication prescription\n\n[Context 4]\nContent: Mrs. Jane Done underwent neck dissection surgery followed by adjuvant therapy with pembrolizumab.\nPersons: Mrs. Jane Done\nRelated Entities: pembrolizumab\nTopic: Surgical and adjuvant cancer treatment\n\n[Context 5]\nContent: Molecular profiling of Mrs. Jane Done revealed the presence of the BRAF V600E mutation.\nPersons: Jane Done\nTopic: Genetic mutation identification\n\n[Context 6]\nContent: A thorough internal check-up including blood tests and liver function tests was conducted for Mrs. Jane Done on 2020-11-23 to rule out systemic side effects of immunotherapy.\nTime: 2020-11-23\nPersons: Jane Done\nTopic: Monitoring for immunotherapy toxicity\n\n[Context 7]\nContent: Immunohistochemistry of Mrs. Jane Done's skin biopsy showed atypical cells positive for HMB-45 and S-100, focally positive for Melan A, and a Ki-67 proliferation index of approximately 10%.\nPersons: Jane Done\nTopic: Immunohistochemical analysis\n\n[Context 8]\nContent: Mrs. Jane Done received the fifth dose of pembrolizumab 200mg on 2018-05-17.\nTime: 2018-05-17T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 9]\nContent: Mrs. Jane Done was prescribed Ipilimumab 200mg intravenously as per the oncologist's advice.\nPersons: Mrs. Jane Done\nRelated Entities: Ipilimumab\nTopic: Medication prescription\n\n[Context 10]\nContent: Mrs. Jane Done received the seventh dose of pembrolizumab 200mg on 2018-06-28.\nTime: 2018-06-28T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 11]\nContent: Mrs. Jane Done has been diagnosed with recurrent metastatic melanoma with lymph node involvement.\nPersons: Jane Done\nTopic: Cancer recurrence diagnosis\n\n[Context 12]\nContent: Mrs. Jane Done was prescribed Nivolumab 60mg intravenously as per the oncologist's advice.\nPersons: Mrs. Jane Done\nRelated Entities: Nivolumab\nTopic: Medication prescription\n\n[Context 13]\nContent: The impression of Mrs. Jane Done's 2020-10-01 thoracic CT scan was multiple subsolid pulmonary nodules requiring follow-up in 4–6 weeks to determine if they are inflammatory or malignant, with no evidence of pathologically enlarged lymph nodes.\nTime: 2020-10-01T00:00:00\nPersons: Mrs. Jane Done\nTopic: Radiological impression and follow-up recommendation\n\n[Context 14]\nContent: Mrs. Jane Done received the second dose of pembrolizumab 200mg on 2018-03-15.\nTime: 2018-03-15T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 15]\nContent: A PET/CT scan performed on 2021-01-02 showed cervical lymph node metastasis in Mrs. Jane Done.\nTime: 2021-01-02T00:00:00\nPersons: Mrs. Jane Done\nTopic: Cancer imaging findings\n\n[Context 16]\nContent: Mrs. Jane Done received the fourth dose of pembrolizumab 200mg on 2018-04-26.\nTime: 2018-04-26T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 17]\nContent: Mrs. Jane Done was diagnosed with malignant melanoma of the left scapula, tumor thickness 16 mm, exophytic ulcerating, invasion stage III, R0.\nPersons: Jane Done\nTopic: Cancer diagnosis details\n\n[Context 18]\nContent: Mrs. Jane Done received the eighth dose of pembrolizumab 200mg on 2018-07-19.\nTime: 2018-07-19T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 19]\nContent: The PET/CT scan on 2021-01-02 revealed metabolically active cervical lymph node metastases in Mrs. Jane Done, with SUVmax values ranging from 6.0 to 7.8 across multiple nodal levels.\nTime: 2021-01-02T00:00:00\nPersons: Mrs. Jane Done\nTopic: Quantitative imaging findings\n\n[Context 20]\nContent: Mrs. Jane Done received the ninth dose of pembrolizumab 200mg intravenously on 2018-08-09.\nTime: 2018-08-09T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 21]\nContent: Mrs. Jane Done received the sixth dose of pembrolizumab 200mg on 2018-06-07.\nTime: 2018-06-07T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 22]\nContent: Mrs. Jane Done received the third dose of pembrolizumab 200mg on 2018-04-05.\nTime: 2018-04-05T00:00:00\nPersons: Jane Done\nRelated Entities: pembrolizumab\nTopic: Systemic therapy administration\n\n[Context 23]\nContent: Current medical recommendations for Mrs. Jane Done include continuing ongoing immunotherapy without changes.\nPersons: Mrs. Jane Done\nTopic: Immunotherapy management\n\n[Context 24]\nContent: A contrast-enhanced cranial MRI (cMRI) performed on 2021-01-02 showed no evidence of metastases but revealed contrast-enhancing meninges in Mrs. Jane Done.\nTime: 2021-01-02T00:00:00\nPersons: Mrs. Jane Done\nTopic: Neuroimaging findings\n\n[Context 25]\nContent: A PET-CT scan was performed on Mrs. Jane Done on 2022-02-11 for follow-up evaluation of metastatic melanoma, Stage IV, M1c.\nTime: 2022-02-11\nPersons: Jane Done\nTopic: Metabolic imaging for cancer staging\n\nQuestion:\nWhat is the tumor proportion score (TPS) for PD-L1 status in Mrs. Done?\n\nOptions:\nA. 0.02\nB. <1%\nC. >1%\nD. TPS not available\nE. 0.03\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804628,
+      "id": "chatcmpl-370f3393-e7c5-94da-a88e-75dfb7fa4b7a",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1998,
+        "total_tokens": 2002
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ba97b03268c58f39.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_ba97b03268c58f39",
+  "timestamp": "2026-04-10T07:08:17.721872+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_12",
+    "question_id": 19,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed mean corpuscular hemoglobin 29.1 pg (reference range 27.0-34.0 pg).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 2]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed hemoglobin 12.3 g/dL (reference range 12.5-17.2 g/dL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 3]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed mean corpuscular hemoglobin concentration 31.5 g/dL (reference range 31.5-36.0 g/dL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 4]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed hematocrit 39.0% (reference range 37.0-49.0%).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 5]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed red blood cells 4.2 M/uL (reference range 4.0-5.6 M/uL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 6]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed mean corpuscular volume 92.4 fL (reference range 80.0-101.0 fL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 7]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed red cell distribution width 13.5% (reference range 11.5-15.0%).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 8]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed mean platelet volume 10.3 fL (reference range 7.0-12.0 fL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 9]\nContent: Mr. Alan Fisher experienced decreased diuresis during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Clinical symptoms\n\n[Context 10]\nContent: During his hospitalization from 2018-04-11 to 2018-12-11, Mr. Alan Fisher's ciclosporin levels remained within the target range.\nPersons: Alan Fisher\nTopic: Immunosuppressant level monitoring\n\n[Context 11]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed platelets 488 K/uL (reference range 150-370 K/uL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 12]\nContent: Mr. Alan Fisher had rising creatinine levels during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Renal laboratory findings\n\n[Context 13]\nContent: Mr. Alan Fisher had no nausea or vomiting during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Absence of gastrointestinal symptoms\n\n[Context 14]\nContent: Mr. Alan Fisher's creatinine increased from 1.56 mg/dL to a maximum of 2.35 mg/dL during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Laboratory value progression\n\n[Context 15]\nContent: During inpatient care from 2020-02-19 to 2020-03-01, Mr. Alan Fisher presented with current symptoms of decreased general condition, weakness, and decompensation.\nTime: 2020-02-19\nPersons: Alan Fisher\nTopic: Presenting symptoms during hospitalization\n\n[Context 16]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed estimated GFR (eGFR) 19 mL/min/1.73m².\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\n[Context 17]\nContent: With volume substitution, Mr. Alan Fisher achieved baseline creatinine levels again.\nPersons: Alan Fisher\nTopic: Renal function improvement\n\n[Context 18]\nContent: Mr. Alan Fisher's antibiotic therapy was extended to include antifungal treatment with Fluconazole on 2020-03-15.\nTime: 2020-03-15T00:00:00\nPersons: Alan Fisher\nRelated Entities: Fluconazole\nTopic: Antifungal treatment initiation\n\n[Context 19]\nContent: Mr. Alan Fisher had no fever or night sweats during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Absence of systemic infection signs\n\n[Context 20]\nContent: Mr. Alan Fisher was under inpatient care from 2009-04-19 to 2009-04-28.\nTime: 2009-04-19T00:00:00\nPersons: Alan Fisher\nTopic: Hospital admission and discharge dates\n\n[Context 21]\nContent: Mr. Alan Fisher's general condition improved within a few days of admission, along with regression of infection parameters.\nTime: 2020-02-22\nPersons: Alan Fisher\nTopic: Clinical response to treatment\n\n[Context 22]\nContent: Mr. Alan Fisher was diagnosed with permanent atrial fibrillation in March 2007, had unsuccessful cardioversion in March 2008, and is anticoagulated with Marcumar.\nTime: 2007-03-01\nPersons: Alan Fisher\nRelated Entities: Marcumar\nTopic: Atrial fibrillation and anticoagulation\n\n[Context 23]\nContent: Upon admission, Mr. Alan Fisher had significantly elevated laboratory infection parameters and slightly worsened renal retention parameters, with creatinine peaking at 3.4 mg/dL compared to a baseline of 3.0 mg/dL.\nTime: 2020-02-19\nPersons: Alan Fisher\nTopic: Laboratory abnormalities at admission\n\n[Context 24]\nContent: Mr. Alan Fisher was diagnosed with acute on chronic graft failure during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Transplant-related diagnosis\n\n[Context 25]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's lab results showed C-reactive Protein 78.3 mg/dL (reference range <5.0 mg/dL).\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nTopic: Laboratory result\n\nQuestion:\nWhat change occurred in Mr. Fisher's hemoglobin levels from April 2009 to March 2020?\n\nOptions:\nA. Levels increased within the normal range\nB. Levels decreased but remained within the normal range\nC. Levels decreased below the normal range\nD. Levels increased above the normal range\nE. Levels remained stable within the reference range\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804895,
+      "id": "chatcmpl-8ba602f5-1a6e-9573-b671-41025ec4f95e",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2112,
+        "total_tokens": 2116
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bb2e0e04dba6e9fe.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bb2e0e04dba6e9fe",
+  "timestamp": "2026-04-10T07:04:22.559775+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_03",
+    "question_id": 8,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: During physical examination in May 2020, Mr. John Williams was alert, responsive, and fully oriented.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Neurological examination finding\n\n[Context 2]\nContent: Abdominal examination of Mr. John Williams in May 2020 showed a soft, non-tender abdomen with normal bowel sounds.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Abdominal examination finding\n\n[Context 3]\nContent: Head, neck, and lung examination of Mr. John Williams in May 2020 was unremarkable.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Physical examination finding\n\n[Context 4]\nContent: A chest X-ray of Mr. John Williams indicated possible inflammation.\nPersons: John Williams\nTopic: Chest X-ray findings\n\n[Context 5]\nContent: Echocardiography of Mr. John Williams in May 2020 showed limited abnormalities with potential mitral valve issues to monitor.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Cardiac imaging finding\n\n[Context 6]\nContent: Diagnostic tests including sonography, whole body CT scan, ophthalmological exams, and histology were conducted on Mr. John Williams during May 2020 admission.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Diagnostic testing\n\n[Context 7]\nContent: Physical examination of Mr. John Williams on November 12, 2022 revealed jugular venous distention, decreased breath sounds bilaterally with mild basilar crackles, and an S3 gallop on cardiac auscultation.\nTime: 2022-11-12T00:00:00\nPersons: John Williams\nTopic: Physical examination findings\n\n[Context 8]\nContent: Extremity examination of Mr. John Williams in May 2020 revealed minor edema.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Peripheral examination finding\n\n[Context 9]\nContent: Mr. John Williams exhibited no fevers and had no known allergies during his May 2020 admission.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Allergy and fever status\n\n[Context 10]\nContent: Mr. John Williams had low appetite and reported no nausea during his May 2020 admission.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Gastrointestinal symptoms\n\n[Context 11]\nContent: Chest X-ray of Mr. John Williams on November 12, 2022 showed cardiomegaly with an enlarged cardiac silhouette and mild pulmonary edema.\nTime: 2022-11-12T00:00:00\nPersons: John Williams\nTopic: Imaging findings\n\n[Context 12]\nContent: On 2015-12-02 and 2015-12-03, chest CT scans of Mr. John Williams showed changes in the lungs and fluid accumulation.\nTime: 2015-12-02T00:00:00\nPersons: John Williams\nTopic: Radiological findings - pulmonary\n\n[Context 13]\nContent: Mr. John Williams had several renal complications documented in June 2018.\nTime: 2018-06-01T00:00:00\nPersons: John Williams\nTopic: Renal complications\n\n[Context 14]\nContent: Mr. John Williams was diagnosed with a respiratory infection confirmed by chest X-ray upon admission on December 13, 2018.\nTime: 2018-12-13T00:00:00\nPersons: John Williams\nTopic: Diagnostic imaging and confirmation\n\n[Context 15]\nContent: On June 13, 2018, Mr. John Williams had laboratory results showing WBC 6.47, Hb 10.8, and platelets 251,000.\nTime: 2018-06-13T00:00:00\nPersons: Mr. John Williams\nTopic: Hematological laboratory values\n\n[Context 16]\nContent: Cardiac auscultation of Mr. John Williams in May 2020 revealed clear and rhythmic heart sounds without abnormal findings.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Cardiac examination finding\n\n[Context 17]\nContent: Mr. John Williams had a non-irritated sternotomy scar during May 2020 physical examination.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Surgical scar observation\n\n[Context 18]\nContent: Mr. John Williams has a known intrusion of the T4 cover plate as identified in a whole spine MRI dated 2018-06-20.\nTime: 2018-06-20\nPersons: Mr. John Williams\nTopic: Spinal lesion detail\n\n[Context 19]\nContent: A whole body CT scan conducted in March 2020 on Mr. John Williams did not show any new osteolyses.\nTime: 2020-03-01T00:00:00\nPersons: John Williams\nTopic: Imaging findings\n\n[Context 20]\nContent: At the time of admission on May 8, 2020, Mr. John Williams felt generally weak but was otherwise in stable condition.\nTime: 2020-05-08T00:00:00\nPersons: John Williams\nTopic: Clinical status at admission\n\n[Context 21]\nContent: Mr. John Williams had jugular vein thrombosis.\nPersons: John Williams\nTopic: Vascular condition\n\n[Context 22]\nContent: Laboratory tests performed on Mr. John Williams showed signs of infection and confirmed chronic kidney disease.\nPersons: John Williams\nTopic: Laboratory findings confirming infection and kidney disease\n\n[Context 23]\nContent: Mr. John Williams had an outpatient visit on December 13, 2018, during which he was diagnosed with febrile respiratory infection.\nTime: 2018-12-13T00:00:00\nPersons: John Williams\nTopic: Diagnosis of febrile respiratory infection\n\n[Context 24]\nContent: Mr. John Williams had secondary diagnoses including Type 2 diabetes mellitus, hypertension, cataract (surgery performed in June 2018), nodular goiter, and RSV pneumonia in March 2018.\nPersons: John Williams\nTopic: Chronic and historical medical conditions\n\n[Context 25]\nContent: Examination of Mr. John Williams's back in May 2020 revealed decubitus ulcers.\nTime: 2020-05-01T00:00:00\nPersons: John Williams\nTopic: Skin condition observation\n\nQuestion:\nWhich sequence of events, as presented in Mr. Williams's detailed medical report, is accurate?\n\nOptions:\nA. Mitral valve reconstruction via minithoracotomy in 2015, multiple myeloma diagnosis in 2015, prostate carcinoma diagnosis in January 2018, followed by brainstem transient ischemic attack (TIA) in March 2020.\nB. Multiple myeloma diagnosis in 2015, acute mitral valve endocarditis in March 2020, mitral valve reconstruction in 2015, followed by prostate carcinoma diagnosis in January 2018.\nC. Mitral valve endocarditis in March 2020, prostate carcinoma diagnosis in January 2018, mitral valve reconstruction in 2015, followed by the first diagnosis of multiple myeloma in 2015.\nD. Prostate carcinoma diagnosis in January 2018, acute mitral valve endocarditis in March 2020, multiple myeloma diagnosis in 2015, followed by mitral valve reconstruction in 2015.\nE. First diagnosis of multiple myeloma in 2015, mitral valve reconstruction in 2015, prostate carcinoma diagnosis in January 2018, and then acute mitral valve endocarditis in March 2020.\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: E",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: E",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804661,
+      "id": "chatcmpl-09a5fb0b-f8c8-99d4-acb6-277684d0e6d1",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2099,
+        "total_tokens": 2103
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bb32f89b04c6a87b.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_bb32f89b04c6a87b",
+  "timestamp": "2026-04-10T06:44:53.567509+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: How many times was glioblastoma resection performed on Mr. John Miller by the reporting facility prior to 2021?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"glioblastoma\", \"resection\", \"Mr. John Miller\", \"reporting facility\", \"2021\"],\n  \"persons\": [\"John Miller\"],\n  \"time_expression\": \"prior to 2021\",\n  \"location\": \"reporting facility\",\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"glioblastoma\", \"resection\", \"Mr. John Miller\", \"reporting facility\", \"2021\"],\n  \"persons\": [\"John Miller\"],\n  \"time_expression\": \"prior to 2021\",\n  \"location\": \"reporting facility\",\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803490,
+      "id": "chatcmpl-593870f8-6d44-9b05-b8d0-fbb25e95a369",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 73,
+        "prompt_tokens": 199,
+        "total_tokens": 272
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bc05269025b1b980.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bc05269025b1b980",
+  "timestamp": "2026-04-10T07:09:53.115875+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_17",
+    "question_id": 3,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Empirical anti-infective therapy with Piperacillin/Tazobactam, Clarithromycin, and Cotrimoxazole was initiated for Mr. Brian Carter due to radiological suspicion of atypical pneumonia.\nPersons: Brian Carter\nTopic: Antibiotic therapy initiation\n\n[Context 2]\nContent: A bedside chest X-ray was performed for Mr. Brian Carter on 2021-10-11 to assess COVID pneumonia and confirm placement of a central venous catheter (CVC).\nTime: 2021-10-11T00:00:00\nPersons: Brian Carter\nTopic: Imaging indication and date\n\n[Context 3]\nContent: Mr. Brian Carter initially received antimicrobial therapy with Piperacillin + Tazobactam, which was escalated to Meropenem on 2021-10-05 due to worsening infection parameters and progression of infiltrates on X-ray.\nTime: 2021-10-05T00:00:00\nPersons: Brian Carter\nRelated Entities: Piperacillin, Tazobactam, Meropenem\nTopic: Antibiotic therapy escalation\n\n[Context 4]\nContent: Mr. Brian Carter's chest X-ray from 2021-10-11 showed no pneumothorax, no pleural effusions, increasing consolidation of infiltrates in the right lower lobe and retrocardially on the left without significant cavitation, and no significant central congestion of the left heart.\nTime: 2021-10-11T00:00:00\nPersons: Brian Carter\nTopic: Radiographic pulmonary and cardiac findings\n\n[Context 5]\nContent: Mr. Brian Carter underwent prone positioning from 2021-09-18 to 2021-10-08 and received NO therapy.\nTime: 2021-09-18T00:00:00\nPersons: Brian Carter\nTopic: Prone positioning and NO therapy\n\n[Context 6]\nContent: Mr. Brian Carter received empirical antibiotic therapy with Piperacillin/Tazobactam starting on 2021-10-02 due to elevated procalcitonin.\nTime: 2021-10-02\nPersons: Brian Carter\nTopic: Empirical antibiotic initiation\n\n[Context 7]\nContent: Mr. Brian Carter underwent intubation on 2021-10-29 due to inadequate oxygenation despite therapy with nasal high flow and mask CPAP.\nTime: 2021-10-29T00:00:00\nPersons: Mr. Brian Carter\nTopic: Intubation due to respiratory failure\n\n[Context 8]\nContent: Mr. Brian Carter was intubated on 2021-09-29 due to inadequate oxygenation despite intensified oxygen therapy with nasal high-flow and mask CPAP.\nTime: 2021-09-29\nPersons: Brian Carter\nTopic: Reason for intubation\n\n[Context 9]\nContent: Starting from 2021-10-11, Mr. Brian Carter received prednisolone with prophylactic Cotrimoxazole therapy.\nTime: 2021-10-11T00:00:00\nPersons: Brian Carter\nRelated Entities: prednisolone, Cotrimoxazole\nTopic: Immunosuppressive and prophylactic therapy\n\n[Context 10]\nContent: CT imaging of Mr. Brian Carter showed bilateral interstitial pneumonia with COVID-typical infiltrates.\nPersons: Brian Carter\nTopic: Radiological findings\n\n[Context 11]\nContent: Mr. Brian Carter received dexamethasone therapy from 2021-09-29 to 2021-10-08.\nPersons: Brian Carter\nTopic: Pharmacological treatment\n\n[Context 12]\nContent: Mr. Brian Carter's antibiotic therapy was escalated to Meropenem on 2021-10-05 and continued until 2021-10-14.\nTime: 2021-10-05\nPersons: Brian Carter\nTopic: Antibiotic escalation\n\n[Context 13]\nContent: Mr. Brian Carter received lung-protective ventilation starting on 2021-10-29 due to severe oxygenation impairment, including inhalational nitric oxide therapy and conservative ARDS management.\nTime: 2021-10-29T00:00:00\nPersons: Mr. Brian Carter\nTopic: Mechanical ventilation strategy for ARDS\n\n[Context 14]\nContent: Mr. Brian Carter received Dexamethasone for 10 days initially during his hospitalization starting from 2021-09-30.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nRelated Entities: Dexamethasone\nTopic: Corticosteroid treatment for COVID-19\n\n[Context 15]\nContent: At transfer, Mr. Brian Carter had a central venous catheter placed on 2021-09-30 and a left radial artery catheter placed on 2021-09-30.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nTopic: Vascular access at transfer\n\n[Context 16]\nContent: A central venous catheter was placed in Mr. Brian Carter on 2021-09-30.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nTopic: Vascular access placement\n\n[Context 17]\nContent: Mr. Brian Carter underwent prone positioning from 2021-09-18 to 2021-10-08 and received nitric oxide (NO) therapy.\nPersons: Brian Carter\nTopic: Respiratory support measures\n\n[Context 18]\nContent: Mr. Brian Carter received lung-protective ventilation with inhaled nitric oxide and conservative ARDS therapy including prone positioning from 2021-09-29 to 2021-10-08.\nTime: 2021-09-29\nPersons: Brian Carter\nTopic: Mechanical ventilation strategy\n\n[Context 19]\nContent: Mr. Brian Carter was intubated on 2021-09-30 and initially extubated on 2021-10-13.\nPersons: Brian Carter\nTopic: Airway management\n\n[Context 20]\nContent: Temporary improvement in Mr. Brian Carter's oxygenation was achieved with differentiated NIV mask ventilation after admission on 2021-09-28.\nTime: 2021-09-28T00:00:00\nPersons: Brian Carter\nTopic: Respiratory therapy response\n\n[Context 21]\nContent: Long-term oxygen therapy at 2 liters per minute was indicated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Oxygen therapy prescription\n\n[Context 22]\nContent: Due to oxygenation impairment despite lung-protective ventilation and inhaled nitric oxide therapy, conservative ARDS therapy including positioning therapy with a total of 9 prone positions was initiated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: ARDS treatment strategy\n\n[Context 23]\nContent: Mucolytic therapy with Ambroxol was initiated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Respiratory supportive therapy\n\n[Context 24]\nContent: Continued speech therapy treatment was requested for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Therapy continuation request\n\n[Context 25]\nContent: A speech therapy consultation for Mr. Brian Carter was recommended.\nPersons: Brian Carter\nTopic: Speech therapy recommendation\n\nQuestion:\nWhat therapy was initiated in Mr. Carter on 09/30/2021 due to radiological suspicion of atypical pneumonia?\n\nOptions:\nA. Methotrexate\nB. Dexamethasone\nC. Piperacillin/Tazobactam, Clarithromycin, and Cotrimoxazole\nD. Meropenem\nE. Voriconazole\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804992,
+      "id": "chatcmpl-1957c8bc-486d-9076-895c-2dc62addbedd",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1947,
+        "total_tokens": 1951
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bc3b34d33b14f91b.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bc3b34d33b14f91b",
+  "timestamp": "2026-04-10T07:10:01.522112+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_17",
+    "question_id": 11,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: On admission, Mr. Brian Carter was taking Methotrexate (Trexall) 25 mg once daily in the morning.\nTime: 2021-09-28T00:00:00\nPersons: Brian Carter\nRelated Entities: Trexall\nTopic: Medication regimen on admission\n\n[Context 2]\nContent: Upon discharge, Mr. Brian Carter was prescribed Methotrexate (Trexall) 15 mg orally once weekly.\nPersons: Brian Carter\nRelated Entities: Trexall\nTopic: Discharge medication prescription\n\n[Context 3]\nContent: Mr. Brian Carter's current medication includes Methotrexate (Trexall) 25 mg once daily in the morning.\nPersons: Brian Carter\nRelated Entities: Trexall\nTopic: Current immunosuppressant medication\n\n[Context 4]\nContent: Upon discharge, Mr. Brian Carter was prescribed Folic Acid 5 mg orally once daily in the evening, taken 48 hours after methotrexate intake.\nPersons: Brian Carter\nTopic: Discharge medication prescription\n\n[Context 5]\nContent: Due to active infection, Methotrexate was paused for Mr. Brian Carter, and after rheumatology consultation, Prednisolone 5mg was continued.\nPersons: Mr. Brian Carter\nRelated Entities: Methotrexate, Prednisolone\nTopic: Immunosuppressant management during infection\n\n[Context 6]\nContent: After complete pulmonary recovery, a rheumatology re-consultation was planned for Mr. Brian Carter with consideration to resume Methotrexate.\nPersons: Mr. Brian Carter\nRelated Entities: Methotrexate\nTopic: Future immunomodulatory therapy planning\n\n[Context 7]\nContent: Ophthalmology colleagues recommended resumption of methotrexate (MTX) therapy for Mr. Brian Carter given his stable vision.\nPersons: Brian Carter\nTopic: Ophthalmology-based MTX recommendation\n\n[Context 8]\nContent: Mr. Brian Carter has a known history of rheumatoid arthritis treated outpatient with Methotrexate and Prednisolone.\nPersons: Mr. Brian Carter\nRelated Entities: Methotrexate, Prednisolone\nTopic: Chronic disease medication history\n\n[Context 9]\nContent: The home medication of Methotrexate and Prednisolone for uveitis was discontinued upon Mr. Brian Carter's admission on 2021-09-30.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nRelated Entities: Methotrexate, Prednisolone\nTopic: Medication discontinuation upon admission\n\n[Context 10]\nContent: Pre-existing immunosuppressive therapy with Prednisolone was discontinued for Mr. Brian Carter and switched to Dexamethasone 10 mg.\nPersons: Brian Carter\nTopic: Immunosuppressive therapy modification\n\n[Context 11]\nContent: Starting from 2021-10-11, Mr. Brian Carter received prednisolone with prophylactic Cotrimoxazole therapy.\nTime: 2021-10-11T00:00:00\nPersons: Brian Carter\nRelated Entities: prednisolone, Cotrimoxazole\nTopic: Immunosuppressive and prophylactic therapy\n\n[Context 12]\nContent: Mr. Brian Carter was admitted for further treatment in a reduced general condition with significant mobility limitations.\nPersons: Brian Carter\nTopic: Hospital admission condition\n\n[Context 13]\nContent: Prophylactic anticoagulation with heparin 500 U/h was initiated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Thromboprophylaxis initiation\n\n[Context 14]\nContent: Mr. Brian Carter received dexamethasone therapy from 2021-09-29 to 2021-10-08.\nPersons: Brian Carter\nTopic: Pharmacological treatment\n\n[Context 15]\nContent: Mr. Brian Carter received Dexamethasone for 10 days initially during his hospitalization starting from 2021-09-30.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nRelated Entities: Dexamethasone\nTopic: Corticosteroid treatment for COVID-19\n\n[Context 16]\nContent: On admission, Mr. Brian Carter was taking Prednisone (Deltasone) 5 mg once daily in the morning.\nTime: 2021-09-28T00:00:00\nPersons: Brian Carter\nRelated Entities: Deltasone\nTopic: Medication regimen on admission\n\n[Context 17]\nContent: On 2021-10-29, Mr. Brian Carter, born on 1956-04-24, was noted to have uveitis/scleritis/episcleritis managed with 10 mg methotrexate weekly and 5 mg prednisolone daily, well-controlled without recurrence, during a cardiology consultation.\nTime: 2021-10-29T00:00:00\nPersons: Brian Carter\nTopic: Autoimmune disease management\n\n[Context 18]\nContent: Long-term oxygen therapy at 2 liters per minute was indicated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Oxygen therapy prescription\n\n[Context 19]\nContent: Mr. Brian Carter's current medication includes Prednisone (Deltasone) 5 mg once daily in the morning.\nPersons: Brian Carter\nRelated Entities: Deltasone\nTopic: Current corticosteroid medication\n\n[Context 20]\nContent: Mucolytic therapy with Ambroxol was initiated for Mr. Brian Carter.\nPersons: Brian Carter\nTopic: Respiratory supportive therapy\n\n[Context 21]\nContent: A rheumatology re-consultation for Mr. Brian Carter was recommended.\nPersons: Brian Carter\nTopic: Rheumatology follow-up recommendation\n\n[Context 22]\nContent: On admission, Mr. Brian Carter had reduced general condition, respiratory rate of 24/min, and oxygen saturation of 97% on 4 L/min oxygen via nasal cannula, which could not be reduced during hospitalization.\nPersons: Mr. Brian Carter\nTopic: Initial clinical presentation on admission\n\n[Context 23]\nContent: Upon admission, Mr. Brian Carter was sedated, intubated, and controlled on mechanical ventilation with mild catecholamine support.\nTime: 2021-09-30T00:00:00\nPersons: Brian Carter\nTopic: Initial critical care management\n\nQuestion:\nRegarding Mr. Carter, what was the primary reason for initiating therapy with Methotrexate (Trexall) 25 mg upon admission?\n\nOptions:\nA. COVID-19 infection\nB. Retinal central serous chorioretinopathy\nC. Uveitis\nD. Rheumatoid arthritis\nE. Depression\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: D",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: D",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775805000,
+      "id": "chatcmpl-b09e60b1-1b47-97d9-b05f-cf5c0b5327bf",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1654,
+        "total_tokens": 1658
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bc641c307b1c9d87.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bc641c307b1c9d87",
+  "timestamp": "2026-04-10T07:06:47.870362+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_09",
+    "question_id": 6,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Paul Wells had pneumogenic sepsis with detection of Streptococcus pneumoniae.\nPersons: Paul Wells\nRelated Entities: Streptococcus pneumoniae\nTopic: Infectious complication\n\n[Context 2]\nContent: Paul Wells developed pneumogenic sepsis with detection of Streptococcus pneumoniae.\nPersons: Paul Wells\nRelated Entities: Streptococcus pneumoniae\nTopic: Sepsis etiology\n\n[Context 3]\nContent: Antibiotic therapy for Paul Wells was adjusted based on sputum culture results that identified Streptococcus pneumoniae as the causative pathogen.\nTime: 2021-02-04\nPersons: Paul Wells\nRelated Entities: Streptococcus pneumoniae\nTopic: Pathogen-directed antibiotic therapy\n\n[Context 4]\nContent: During hospitalization from 2021-02-04 to 2021-02-12, Paul Wells received empiric antibiotic therapy with intravenous Ceftriaxone and Azithromycin for community-acquired pneumonia.\nTime: 2021-02-04\nPersons: Paul Wells\nRelated Entities: Ceftriaxone, Azithromycin\nTopic: Empiric antibiotic treatment\n\n[Context 5]\nContent: After discharge from hospitalization in October 2019, Paul Wells had a recurrent infection requiring inpatient antibiotic therapy.\nTime: 2019-10-01T00:00:00\nPersons: Paul Wells\nTopic: Post-discharge infection recurrence\n\n[Context 6]\nContent: During his hospitalization from 2021-02-04 to 2021-02-12, Paul Wells complained of progressively worsening respiratory symptoms including shortness of breath, productive cough with yellow-green sputum, pleuritic chest pain, fever, and chills over five days.\nTime: 2021-02-04\nPersons: Paul Wells\nTopic: Acute pneumonia symptom presentation\n\n[Context 7]\nContent: Paul Wells had a history of unclear infection versus pneumonia between October 2019 and January 2020.\nTime: 2019-10-01\nPersons: Paul Wells\nTopic: Unclear respiratory illness episode\n\n[Context 8]\nContent: Paul Wells, born on 1953-04-02, received inpatient treatment from 2021-02-04 to 2021-02-12 for community-acquired pneumonia.\nTime: 2021-02-04\nPersons: Paul Wells\nTopic: Hospital admission for pneumonia\n\n[Context 9]\nContent: Paul Wells was diagnosed with community-acquired pneumonia during his hospitalization from 2021-02-04 to 2021-02-12.\nTime: 2021-02-04\nPersons: Paul Wells\nTopic: Pneumonia diagnosis\n\n[Context 10]\nContent: Paul Wells exhibited gradual clinical improvement during hospitalization, including resolution of fever, improved oxygen saturation, and radiographic resolution of right lower lobe consolidation on follow-up chest X-ray.\nTime: 2021-02-12\nPersons: Paul Wells\nTopic: Clinical and radiographic recovery\n\n[Context 11]\nContent: Mr. Paul Wells has no known allergies.\nPersons: Paul Wells\nTopic: Allergy status\n\n[Context 12]\nContent: On 2020-08-13, perfusion scintigraphy with SPECT/CT showed a liver/lung shunt volume of 9.4% in Paul Wells.\nTime: 2020-08-13T00:00:00\nPersons: Paul Wells\nTopic: Radiological shunt quantification\n\n[Context 13]\nContent: Pulmonary hygiene measures and chest physiotherapy were applied to Paul Wells to facilitate sputum clearance during hospitalization.\nTime: 2021-02-04\nPersons: Paul Wells\nTopic: Airway clearance interventions\n\n[Context 14]\nContent: Upon discharge, Paul Wells had a neutrophil count of 3.72 K/µL, within the reference range of 1.8-7.7 K/µL.\nPersons: Paul Wells\nTopic: White blood cell differential\n\n[Context 15]\nContent: Tumor marker diagnostics for Mr. Paul Wells were inconclusive.\nPersons: Paul Wells\nTopic: Laboratory diagnostics\n\n[Context 16]\nContent: Upon discharge, Paul Wells had a CRP level of 0.19 mg/dL, within the reference range of less than 0.5 mg/dL.\nPersons: Paul Wells\nTopic: Inflammatory marker lab result\n\n[Context 17]\nContent: Computer tomography of Mr. Paul Wells showed multiple intrahepatic masses in the right liver lobe (segments IV, VII/VIII).\nPersons: Paul Wells\nTopic: Imaging findings\n\n[Context 18]\nContent: Chest CT of Mr. Paul Wells showed marked coronary sclerosis, aortic and mitral valve calcification, small nonspecific lung nodules, and centrilobular emphysema with basal scarring.\nPersons: Paul Wells\nTopic: Thoracic CT findings\n\n[Context 19]\nContent: Pancreas, spleen, kidneys, and bone marrow of Mr. Paul Wells appeared unremarkable on MRI.\nPersons: Paul Wells\nTopic: Normal organ findings on MRI\n\n[Context 20]\nContent: Mr. Paul Wells has pulmonary emphysema with respiratory partial insufficiency requiring home oxygen therapy.\nPersons: Paul Wells\nTopic: Pulmonary comorbidity\n\n[Context 21]\nContent: Paul Wells had respiratory partial insufficiency requiring home oxygen therapy.\nPersons: Paul Wells\nTopic: Chronic respiratory support need\n\n[Context 22]\nContent: Paul Wells had a history of severe pneumonia at Medical Center St. Luke's in October 2019.\nTime: 2019-10-01T00:00:00\nLocation: Medical Center St. Luke's\nPersons: Paul Wells\nRelated Entities: Medical Center St. Luke's\nTopic: Infectious complication history\n\n[Context 23]\nContent: As of the 2020-11-20 follow-up, Paul Wells' COPD, emphysema, and respiratory insufficiency remained stable with no acute deterioration.\nTime: 2020-11-20T00:00:00\nPersons: Paul Wells\nTopic: Respiratory disease stability\n\n[Context 24]\nContent: Mr. Paul Wells was born on 1953-04-02 and received inpatient treatment from 2019-07-26 to 2019-07-28.\nPersons: Paul Wells\nTopic: Patient demographic and admission information\n\nQuestion:\nWhat was the causative pathogen for Mr. Wells' pneumogenic sepsis?\n\nOptions:\nA. Haemophilus influenzae\nB. Streptococcus pneumoniae\nC. Klebsiella pneumoniae\nD. Mycoplasma pneumoniae\nE. Legionella pneumophila\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804807,
+      "id": "chatcmpl-c7d2b7ad-7474-94cd-bad2-385e55e97ce1",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1691,
+        "total_tokens": 1695
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bd3e53aabc822489.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bd3e53aabc822489",
+  "timestamp": "2026-04-10T07:07:20.720838+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_10",
+    "question_id": 13,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mr. Peter Rudolph had suspected soft tissue rheumatism but reported no current complaints related to it.\nPersons: Peter Rudolph\nTopic: Rheumatological history\n\n[Context 2]\nContent: Mr. Peter Rudolph has a good social network and does not require nursing care.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nTopic: Social support status\n\n[Context 3]\nContent: Mr. Peter Rudolph has a history of soft tissue rheumatism.\nPersons: Peter Rudolph\nTopic: Rheumatological condition\n\n[Context 4]\nContent: Mr. Peter Rudolph has suspected soft tissue rheumatism.\nPersons: Peter Rudolph\nTopic: Rheumatological condition\n\n[Context 5]\nContent: Physical examination of Mr. Peter Rudolph revealed a soft abdomen with no pressure pain.\nPersons: Peter Rudolph\nTopic: Physical examination findings\n\n[Context 6]\nContent: Mr. Peter Rudolph had a tonsillectomy at an unspecified time.\nPersons: Peter Rudolph\nTopic: Surgical history\n\n[Context 7]\nContent: Mr. Peter Rudolph had a tonsillectomy at an unknown date.\nPersons: Peter Rudolph\nTopic: Surgical history\n\n[Context 8]\nContent: Mr. Peter Rudolph underwent tonsillectomy at an unspecified time.\nPersons: Peter Rudolph\nTopic: ENT surgery\n\n[Context 9]\nContent: Mr. Peter Rudolph was under medical care from 2019-01-16 to 2019-01-17.\nTime: 2019-01-16T00:00:00\nPersons: Peter Rudolph\nTopic: Patient care period\n\n[Context 10]\nContent: Mr. Peter Rudolph was under medical care from 2019-03-17 to 2019-04-01.\nPersons: Peter Rudolph\nTopic: Hospital admission period\n\n[Context 11]\nContent: The CT thorax of Mr. Peter Rudolph on 2019-01-16 confirmed a history of cholecystectomy.\nTime: 2019-01-16T00:00:00\nPersons: Peter Rudolph\nTopic: Surgical history confirmation via imaging\n\n[Context 12]\nContent: Mr. Peter Rudolph underwent tonsillectomy at an unknown date.\nPersons: Peter Rudolph\nTopic: ENT surgery\n\n[Context 13]\nContent: Mr. Peter Rudolph has a history of tonsillectomy.\nPersons: Peter Rudolph\nTopic: Surgical history\n\n[Context 14]\nContent: Mr. Peter Rudolph reported occasional mild discomfort in the left upper abdomen.\nPersons: Peter Rudolph\nTopic: Patient symptom report\n\n[Context 15]\nContent: The CT thorax of Mr. Peter Rudolph on 2019-01-16 showed no suspicious lung lesions, no pleural effusions, and no infiltrates.\nTime: 2019-01-16T00:00:00\nPersons: Peter Rudolph\nTopic: Pulmonary imaging findings\n\n[Context 16]\nContent: During physical examination on 2022-03-04, Mr. Peter Rudolph had an unremarkable scar with sutures in place.\nTime: 2022-03-04T00:00:00\nPersons: Peter Rudolph\nTopic: Postoperative physical examination\n\n[Context 17]\nContent: Mr. Peter Rudolph, born on 1954-05-26, was under treatment at an outpatient clinic on 2020-04-20.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nTopic: Patient outpatient visit\n\n[Context 18]\nContent: Mr. Peter Rudolph has obesity.\nPersons: Peter Rudolph\nTopic: Chronic condition\n\n[Context 19]\nContent: The skeletal assessment for Mr. Peter Rudolph revealed degenerative changes in the spine and no evidence of suspicious lesions.\nPersons: Peter Rudolph\nTopic: Skeletal imaging findings\n\n[Context 20]\nContent: The CT thorax of Mr. Peter Rudolph on 2019-01-16 showed no evidence of suspicious retrocrural lymph nodes and noted vascular sclerosis.\nTime: 2019-01-16T00:00:00\nPersons: Peter Rudolph\nTopic: Lymph node and vascular imaging findings\n\n[Context 21]\nContent: Mr. Peter Rudolph, born on 1954-05-26, presented at an outpatient clinic on 2021-06-29.\nTime: 2021-06-29T00:00:00\nPersons: Peter Rudolph\nTopic: Patient clinic visit\n\n[Context 22]\nContent: Mr. Peter Rudolph, born on 1954-05-26, underwent an examination on 2021-08-26.\nTime: 2021-08-26T00:00:00\nPersons: Peter Rudolph\nTopic: Patient examination\n\nQuestion:\nWhich of the following is NOT a part of Mr. Rudolph's medical history?\n\nOptions:\nA. Atrial fibrillation with ablation\nB. pTCA stenting for acute myocardial infarction/CHD\nC. Laparoscopic cholecystectomy\nD. Left psoas abscess\nE. Prostatectomy\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: A",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: A",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804840,
+      "id": "chatcmpl-4e110dda-046b-9dbf-b190-aa4bc96ff042",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1358,
+        "total_tokens": 1362
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bd62afa734e7140b.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_bd62afa734e7140b",
+  "timestamp": "2026-04-10T06:41:08.658535+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Regarding Mrs. Done, hat is the parameter mentioned that warrants immediate medical attention according to the treatment regimen?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mrs. Done\", \"parameter\", \"immediate medical attention\", \"treatment regimen\"],\n  \"persons\": [\"Mrs. Done\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mrs. Done\", \"parameter\", \"immediate medical attention\", \"treatment regimen\"],\n  \"persons\": [\"Mrs. Done\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803266,
+      "id": "chatcmpl-5b1ef52f-c3f5-976f-abc7-dd3e3c727d8c",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 56,
+        "prompt_tokens": 192,
+        "total_tokens": 248
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_be043131c8e034ee.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_be043131c8e034ee",
+  "timestamp": "2026-04-10T06:54:38.610990+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which of the following side effects did Mr. Harder not experience after his last treatment cycle as per the information provided?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"side effects\", \"treatment cycle\"],\n  \"persons\": [\"Mr. Harder\"],\n  \"time_expression\": \"after his last treatment cycle\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"side effects\", \"treatment cycle\"],\n  \"persons\": [\"Mr. Harder\"],\n  \"time_expression\": \"after his last treatment cycle\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804074,
+      "id": "chatcmpl-1c9841e3-834f-9e93-8ad3-51d5b4d5eaaa",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 52,
+        "prompt_tokens": 195,
+        "total_tokens": 247
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_be2b1015ab63516a.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_be2b1015ab63516a",
+  "timestamp": "2026-04-10T06:51:56.552730+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What was Mr. Hurley's Hemoglobin level upon last recorded discharge?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mr. Hurley\", \"Hemoglobin\", \"level\", \"discharge\"],\n  \"persons\": [\"Mr. Hurley\"],\n  \"time_expression\": \"upon last recorded discharge\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mr. Hurley\", \"Hemoglobin\", \"level\", \"discharge\"],\n  \"persons\": [\"Mr. Hurley\"],\n  \"time_expression\": \"upon last recorded discharge\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803914,
+      "id": "chatcmpl-45776b8d-82bd-9323-80f1-504de72023fa",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 60,
+        "prompt_tokens": 186,
+        "total_tokens": 246
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_be501643cc83bce9.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_be501643cc83bce9",
+  "timestamp": "2026-04-10T07:03:16.439667+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: How did Mrs. Sanders' platelet count on 11/15/2019 compare to her platelet count on 03/04/2017?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mrs. Sanders\", \"platelet count\", \"11/15/2019\", \"03/04/2017\"],\n  \"persons\": [\"Mrs. Sanders\"],\n  \"time_expression\": \"11/15/2019 and 03/04/2017\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mrs. Sanders\", \"platelet count\", \"11/15/2019\", \"03/04/2017\"],\n  \"persons\": [\"Mrs. Sanders\"],\n  \"time_expression\": \"11/15/2019 and 03/04/2017\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804592,
+      "id": "chatcmpl-08b29be1-c1b4-9437-9bae-c45fd7815328",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 93,
+        "prompt_tokens": 211,
+        "total_tokens": 304
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_be5c143169630d7f.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_be5c143169630d7f",
+  "timestamp": "2026-04-10T07:11:18.445840+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_20",
+    "question_id": 13,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Esophagogastroduodenoscopy performed on Mrs. Hilary Sanders, born on 1976-08-24, on 2023-04-01 revealed erythematous antral gastritis and an approximately 1 cm irregular mucosal area at the corpus-antrum junction on the greater curvature side.\nTime: 2023-04-01T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Upper endoscopy findings\n\n[Context 2]\nContent: A current gastroscopy was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Gastrointestinal diagnostic recommendation\n\n[Context 3]\nContent: Outpatient endoscopic diagnostics were recommended for Mrs. Hilary Sanders as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 4]\nContent: Multiple glandular cysts less than 8 mm in size were observed in the fundus and corpus of the stomach of Mrs. Hilary Sanders, born on 1976-08-24, during esophagogastroduodenoscopy on 2023-04-01.\nTime: 2023-04-01T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastric cyst findings\n\n[Context 5]\nContent: Capsule endoscopy performed on Mrs. Hilary Sanders, born on 1976-08-24, was incomplete but showed no evidence of inflammatory changes; some hyperemia and blurry vascular pattern were observed in the visible colon.\nPersons: Mrs. Hilary Sanders\nTopic: Capsule endoscopy findings\n\n[Context 6]\nContent: External upper gastrointestinal endoscopy and colonoscopy are recommended for Mrs. Hilary Sanders, with a request to return with findings.\nPersons: Mrs. Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 7]\nContent: An external upper gastrointestinal endoscopy and colonoscopy were recommended for Mrs. Hilary Sanders as of 2018-04-12, with a request to return with findings.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 8]\nContent: Outpatient endoscopic diagnostics were recommended for Mrs. Hilary Sanders as of 2018-04-12 to investigate persistent diarrhea.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Diagnostic recommendation\n\n[Context 9]\nContent: As of 2020-02-12, Mrs. Hilary Sanders had adapted to her gastrointestinal issues and had an appointment scheduled with the Gastroenterology department.\nTime: 2020-02-12T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal symptom management\n\n[Context 10]\nContent: As of 2018-02-10, gastroscopy approximately every 2-3 years, depending on previous findings and Helicobacter pylori testing, was recommended for Mrs. Hilary Sanders.\nTime: 2018-02-10\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 11]\nContent: Mrs. Hilary Sanders was recommended to undergo external upper gastrointestinal endoscopy and colonoscopy, with a request to return with findings, as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal diagnostic recommendation\n\n[Context 12]\nContent: Follow-up in the gastroenterological outpatient clinic was recommended for Mrs. Hilary Sanders, born on 1976-08-24, after discharge on 2023-04-05.\nTime: 2023-04-05T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Post-discharge care recommendation\n\n[Context 13]\nContent: On 2020-04-14, referral to Gastroenterology was recommended for Mrs. Hilary Sanders due to persistent abdominal symptoms.\nTime: 2020-04-14T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Specialist referral\n\n[Context 14]\nContent: As of 2020-02-12, Mrs. Hilary Sanders had not had a gastroscopy or colonoscopy for some time.\nTime: 2020-02-12T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal endoscopy status\n\n[Context 15]\nContent: On 2017-10-06, Mrs. Hilary Sanders underwent an abdominal ultrasound showing a morphologically unremarkable pancreas with no space-occupying processes visible despite intestinal gas overlay.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Abdominal imaging finding\n\n[Context 16]\nContent: Gastroscopy approximately every 2-3 years, depending on previous findings or H. pylori testing, was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 17]\nContent: The CT scan on 03/04/2017 showed normal trachea and esophagus appearance and no evidence of hiatus hernia.\nTime: 2017-03-04T00:00:00\nTopic: Upper GI and airway CT findings\n\n[Context 18]\nContent: Gastroscopy approximately every 2-3 years, depending on previous findings and Helicobacter pylori testing, was recommended for Mrs. Hilary Sanders as of 2018-04-12.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 19]\nContent: Mrs. Hilary Sanders was recommended to have gastroscopy approximately every 2-3 years depending on previous findings and Helicobacter pylori testing results, as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Periodic gastroscopy recommendation\n\n[Context 20]\nContent: As of 2018-02-10, Mrs. Hilary Sanders experienced ongoing diarrhea in the morning, often recurring in the afternoon, with no melena and no fresh blood.\nTime: 2018-02-10\nPersons: Hilary Sanders\nTopic: Gastrointestinal symptom description\n\n[Context 21]\nContent: On 2017-10-06, Mrs. Hilary Sanders underwent an abdominal ultrasound showing a gallbladder and biliary tract without calculi, inflammation, or congestion.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Abdominal imaging finding\n\n[Context 22]\nContent: Mrs. Hilary Sanders, born on 1976-08-24, experienced intermittent left-sided upper abdominal pain primarily after meals during her hospitalization from 2023-03-29 to 2023-04-05.\nPersons: Mrs. Hilary Sanders\nTopic: Abdominal symptom description\n\n[Context 23]\nContent: Annual H. pylori testing via breath test or stool antigen was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Gastrointestinal infection screening recommendation\n\n[Context 24]\nContent: Granulomas were not observed in the liver biopsy of Mrs. Hilary Sanders, born on 1976-08-24.\nPersons: Mrs. Hilary Sanders\nTopic: Histopathology finding\n\n[Context 25]\nContent: Chest X-ray or CT thorax was recommended for Mrs. Hilary Sanders if clinical symptoms or lung function abnormalities are observed as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Thoracic imaging recommendation\n\nQuestion:\nIn March 2023, what was observed during Mrs. Sanders' esophagogastroduodenoscopy (EGD)?\n\nOptions:\nA. Duodenal Ulcers\nB. Erythematous Antral Gastritis\nC. Esophageal Varices\nD. Gastric Polyps\nE. Barrett's Esophagus\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775805077,
+      "id": "chatcmpl-6c22dbd8-4183-98d0-ae3b-d2aaec1d90c8",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2245,
+        "total_tokens": 2249
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_be986c3d24bdbcd2.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_be986c3d24bdbcd2",
+  "timestamp": "2026-04-10T06:49:34.713153+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What did the MRI Liver on 11/20/2020 reveal about Mr. Wells' hepatic lesions\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"MRI\", \"Liver\", \"hepatic lesions\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"11/20/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"MRI\", \"Liver\", \"hepatic lesions\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"11/20/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803771,
+      "id": "chatcmpl-b0a451c7-9af5-91e6-8ff3-717ec4122ba0",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 59,
+        "prompt_tokens": 198,
+        "total_tokens": 257
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bebb057b57c41148.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_bebb057b57c41148",
+  "timestamp": "2026-04-10T06:54:57.005934+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which of the following statements accurately reflects the trend in Mr. Ben Harder's lab results from December 2015 to June 2023?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mr. Ben Harder\", \"lab results\", \"trend\"],\n  \"persons\": [\"Ben Harder\"],\n  \"time_expression\": \"December 2015 to June 2023\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mr. Ben Harder\", \"lab results\", \"trend\"],\n  \"persons\": [\"Ben Harder\"],\n  \"time_expression\": \"December 2015 to June 2023\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804094,
+      "id": "chatcmpl-46456bfa-5b85-9a92-956e-408ed6eec0c2",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 65,
+        "prompt_tokens": 204,
+        "total_tokens": 269
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bec1db844bf46a4a.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_bec1db844bf46a4a",
+  "timestamp": "2026-04-10T07:01:23.409499+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What abnormality was observed in Mr. Nilsson's ECG on July 2nd 2008?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"abnormality\", \"ECG\", \"Mr. Nilsson\"],\n  \"persons\": [\"Mr. Nilsson\"],\n  \"time_expression\": \"July 2nd 2008\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"abnormality\", \"ECG\", \"Mr. Nilsson\"],\n  \"persons\": [\"Mr. Nilsson\"],\n  \"time_expression\": \"July 2nd 2008\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804480,
+      "id": "chatcmpl-c02f81c4-712b-9ede-aca6-fc69b29bb8bb",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 62,
+        "prompt_tokens": 195,
+        "total_tokens": 257
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bef057ae9e0aef27.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bef057ae9e0aef27",
+  "timestamp": "2026-04-10T07:10:34.551633+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_18",
+    "question_id": 18,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: At discharge on 2016-03-30, Mr. David Romero's medication included Aspirin 100 mg once daily in the morning.\nTime: 2016-03-30T00:00:00\nPersons: David Romero\nRelated Entities: Aspirin\nTopic: Discharge medication - antiplatelet\n\n[Context 2]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Aspirin 100 mg once daily in the morning.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nTopic: Medication regimen at discharge\n\n[Context 3]\nContent: Upon admission on 2016-07-04, Mr. David Romero's medication included Aspirin 100 mg once daily in the morning.\nTime: 2016-07-04\nPersons: David Romero\nTopic: Medication regimen\n\n[Context 4]\nContent: At discharge on 2016-03-30, Mr. David Romero's medication included Carvedilol (Coreg) 12.5 mg twice daily (morning and evening).\nTime: 2016-03-30T00:00:00\nPersons: David Romero\nRelated Entities: Carvedilol, Coreg\nTopic: Discharge medication - beta blocker\n\n[Context 5]\nContent: Mr. David Romero's current medication regimen as of 2016-08-26 includes Aspirin 100 mg once daily in the morning.\nTime: 2016-08-26T00:00:00\nPersons: David Romero\nTopic: Medication regimen\n\n[Context 6]\nContent: Mr. David Romero's medication regimen as of 2023-09-29 includes Demadex (Torasemide) at 5 mg administered once daily in the late afternoon or early evening at half dose.\nTime: 2023-09-29T00:00:00\nPersons: David Romero\nRelated Entities: Demadex, Torasemide\nTopic: Diuretic medication regimen\n\n[Context 7]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Torasemide (Torem) 5 mg half dose in the evening.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nRelated Entities: Torem\nTopic: Medication regimen at discharge\n\n[Context 8]\nContent: Upon admission on 2023-05-20, Mr. David Romero's medication included Aspirin 100 mg once daily in the morning.\nTime: 2023-05-20T00:00:00\nPersons: David Romero\nTopic: Medication regimen at admission\n\n[Context 9]\nContent: Mr. David Romero's medication regimen as of 2023-09-29 includes Vitamin D3 (Colecalciferol) at 12.5 mcg administered twice daily in the morning.\nTime: 2023-09-29T00:00:00\nPersons: David Romero\nRelated Entities: Vitamin D3, Colecalciferol\nTopic: Supplement regimen\n\n[Context 10]\nContent: At discharge on 2016-03-30, Mr. David Romero's medication included Torasemide (Torem) 5 mg once daily in the morning.\nTime: 2016-03-30T00:00:00\nPersons: David Romero\nRelated Entities: Torasemide, Torem\nTopic: Discharge medication - loop diuretic\n\n[Context 11]\nContent: Mr. David Romero was under inpatient care from 2016-03-25 to 2016-03-30.\nTime: 2016-03-25T00:00:00\nPersons: David Romero\nTopic: Hospital admission and discharge dates\n\n[Context 12]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Colecalciferol (Vitamin D3) 12.5 µg twice daily in the morning and midday.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nTopic: Medication regimen at discharge\n\n[Context 13]\nContent: Mr. David Romero's medication regimen as of 2023-09-29 includes Aspirin at 100 mg administered once daily in the morning.\nTime: 2023-09-29T00:00:00\nPersons: David Romero\nRelated Entities: Aspirin\nTopic: Antiplatelet medication regimen\n\n[Context 14]\nContent: At discharge on 2016-03-30, Mr. David Romero's medication included Ramipril (Altace) 2.5 mg twice daily (morning and evening).\nTime: 2016-03-30T00:00:00\nPersons: David Romero\nRelated Entities: Ramipril, Altace\nTopic: Discharge medication - ACE inhibitor\n\n[Context 15]\nContent: Mr. David Romero's medication regimen as of 2023-09-29 includes Coreg (Carvedilol) at 25 mg administered twice daily in the morning and evening at half dose each time.\nTime: 2023-09-29T00:00:00\nPersons: David Romero\nRelated Entities: Coreg, Carvedilol\nTopic: Beta-blocker medication regimen\n\n[Context 16]\nContent: Mr. David Romero's current medication regimen as of 2016-08-26 includes Torasemide (Torem) 5 mg once daily in the morning.\nTime: 2016-08-26T00:00:00\nPersons: David Romero\nRelated Entities: Torem\nTopic: Medication regimen\n\n[Context 17]\nContent: Upon admission on 2023-05-20, Mr. David Romero's medication included Torasemide (Torem) 5 mg half dose in the evening.\nTime: 2023-05-20T00:00:00\nPersons: David Romero\nRelated Entities: Torem\nTopic: Medication regimen at admission\n\n[Context 18]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Simvastatin (Zocor) 40 mg half dose in the evening.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nRelated Entities: Zocor\nTopic: Medication regimen at discharge\n\n[Context 19]\nContent: Mr. David Romero's current medication includes Aspirin 100 mg once daily in the morning.\nPersons: David Romero\nTopic: Medication regimen\n\n[Context 20]\nContent: Mr. David Romero's current medication regimen as of 2016-08-26 includes Carvedilol (Coreg) 12.5 mg twice daily, in the morning and evening.\nTime: 2016-08-26T00:00:00\nPersons: David Romero\nRelated Entities: Coreg\nTopic: Medication regimen\n\n[Context 21]\nContent: Mr. David Romero completed antiviral therapy prior to his inpatient stay from 2016-03-25 to 2016-03-30.\nPersons: David Romero\nTopic: Antiviral treatment history\n\n[Context 22]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Carvedilol (Coreg) 25 mg half dose in the morning and half dose in the evening.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nRelated Entities: Coreg\nTopic: Medication regimen at discharge\n\n[Context 23]\nContent: Upon discharge on 2023-05-21, Mr. David Romero's medication included Amlodipine (Norvasc) 6.94 mg once daily in the morning.\nTime: 2023-05-21T00:00:00\nPersons: David Romero\nRelated Entities: Norvasc\nTopic: Medication regimen at discharge\n\n[Context 24]\nContent: Mr. David Romero's current medication regimen as of 2016-08-26 includes Ramipril (Altace) 2.5 mg twice daily, in the morning and evening.\nTime: 2016-08-26T00:00:00\nPersons: David Romero\nRelated Entities: Altace\nTopic: Medication regimen\n\n[Context 25]\nContent: Upon admission on 2023-05-20, Mr. David Romero's medication included Colecalciferol 12.5 mcg twice daily in the morning and midday.\nTime: 2023-05-20T00:00:00\nPersons: David Romero\nTopic: Medication regimen at admission\n\nQuestion:\nWhich of Mr. Romero's medications, present in both March 2016 and May 2023, had a change in its dosing frequency?\n\nOptions:\nA. Ramipril (Altace)\nB. Torasemide (Torem)\nC. Carvedilol (Coreg)\nD. Aspirin\nE. L-Thyroxine (Synthroid)\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775805033,
+      "id": "chatcmpl-9faa5572-a250-96df-a927-c8e9f0a36e3f",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2362,
+        "total_tokens": 2366
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_bfbeaf66bd816fd6.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_bfbeaf66bd816fd6",
+  "timestamp": "2026-04-10T07:06:45.567981+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_09",
+    "question_id": 4,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: After Atezolizumab/Bevacizumab administration on 2020-02-14, Paul Wells experienced significant side effects including oral burning, appetite and weight loss, low blood pressure, and worsening pulmonary status.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Adverse effects of immunotherapy\n\n[Context 2]\nContent: Paul Wells experienced transient worsening of lung function requiring steroid treatment after administrations of Atezolizumab and Bevacizumab.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Pulmonary side effect of immunotherapy\n\n[Context 3]\nContent: Paul Wells was hospitalized in October 2019 for severe pneumonic sepsis before the next planned administration of Atezolizumab/Bevacizumab.\nTime: 2019-10-01T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Hospitalization due to infection\n\n[Context 4]\nContent: Paul Wells experienced transient worsening of lung function requiring steroid treatment after Atezolizumab/Bevacizumab administrations.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Pulmonary adverse reaction to immunotherapy\n\n[Context 5]\nContent: Steroid treatment improved Paul Wells' pulmonary situation after Atezolizumab/Bevacizumab-related side effects.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Management of pulmonary adverse effects\n\n[Context 6]\nContent: Atezolizumab/Bevacizumab was re-administered to Paul Wells after a prior pause.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Resumption of systemic therapy\n\n[Context 7]\nContent: After comprehensive counseling, Paul Wells commenced treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Informed consent and treatment start\n\n[Context 8]\nContent: Paul Wells started treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Initiation of immunotherapy\n\n[Context 9]\nContent: Due to poor tolerance, Atezolizumab/Bevacizumab therapy was paused after 2020-02-14 in Paul Wells.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Discontinuation of systemic therapy\n\n[Context 10]\nContent: Paul Wells experienced a substantial increase in transaminases (GPT 164 U/L, GOT 151 U/L) after one administration of Atezolizumab/Bevacizumab, suspected to be immunotherapy-induced hepatitis.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Hepatotoxicity from immunotherapy\n\n[Context 11]\nContent: Paul Wells initiated treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy initiation\n\n[Context 12]\nContent: Paul Wells was extensively informed about systemic therapy options including Atezolizumab/Bevacizumab and alternative therapy with a tyrosine kinase inhibitor.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab, tyrosine kinase inhibitor\nTopic: Therapy options counseling\n\n[Context 13]\nContent: Atezolizumab and Bevacizumab were re-administered to Paul Wells on 2022-01-25 and 2022-02-16, followed by another treatment pause due to limited tolerance.\nTime: 2022-01-25\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Re-initiation and discontinuation of immunotherapy\n\n[Context 14]\nContent: Paul Wells received re-administration of Atezolizumab and Bevacizumab on 2020-01-23 and 2020-02-14.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy re-initiation\n\n[Context 15]\nContent: Paul Wells received re-administration of Atezolizumab and Bevacizumab on 2022-01-25 and 2022-02-16, followed by a treatment pause due to limited tolerance.\nTime: 2022-02-16T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy re-administration and discontinuation\n\n[Context 16]\nContent: Paul Wells received Atezolizumab/Bevacizumab treatment starting on 2021-10-26, with a pause initiated on 2019-09-17 due to transaminase elevation.\nTime: 2021-10-26T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy administration and interruption\n\n[Context 17]\nContent: Paul Wells paused Atezolizumab and Bevacizumab treatment starting on 2019-09-17 due to transaminase elevation up to 4 times the upper limit of normal.\nTime: 2019-09-17\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Treatment interruption due to liver toxicity\n\n[Context 18]\nContent: As of the 2020-11-20 follow-up, Paul Wells' hepatocellular carcinoma remained stable with no significant progression or new metastases.\nTime: 2020-11-20T00:00:00\nPersons: Paul Wells\nTopic: Overall oncological assessment\n\n[Context 19]\nContent: Staging examinations in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Tumor staging result\n\n[Context 20]\nContent: A CT scan in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Imaging-based tumor response assessment\n\n[Context 21]\nContent: A CT scan performed in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01\nPersons: Paul Wells\nTopic: Imaging response assessment\n\n[Context 22]\nContent: The latest CT examination as of 2020-10-24 showed continued tumor regression in Paul Wells.\nTime: 2020-10-24T00:00:00\nPersons: Paul Wells\nTopic: Imaging tumor response\n\n[Context 23]\nContent: A computed tomography (CT) scan performed in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Imaging-based tumor response assessment\n\nQuestion:\nWhich of the following complications did Mr. Wells not experience after the administration of Atezolizumab/Bevacizumab?\n\nOptions:\nA. High blood pressure\nB. Elevated transaminases\nC. Worsening pulmonary status\nD. Severe pneumonic sepsis\nE. Oral burning\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: A",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: A",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804804,
+      "id": "chatcmpl-733d9c61-50c7-97b7-b435-bc10b513583b",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2128,
+        "total_tokens": 2132
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c08c521803dc69b4.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c08c521803dc69b4",
+  "timestamp": "2026-04-10T07:07:26.322832+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_10",
+    "question_id": 17,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: From May 2020 to September 2020, Mr. Peter Rudolph received 10 cycles of immunotherapy with Nivolumab 240 mg every 14 days.\nTime: 2020-05-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Nivolumab\nTopic: Immunotherapy treatment\n\n[Context 2]\nContent: Mr. Peter Rudolph received 10 cycles of immunotherapy with Nivolumab 240 mg every 14 days from May 2020 to September 2020.\nTime: 2020-05-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Nivolumab\nTopic: Immunotherapy treatment\n\n[Context 3]\nContent: From October 2020 to June 2021, Mr. Peter Rudolph received third-line chemotherapy with Vinflunin from an external provider, which resulted in hepatic progression.\nTime: 2020-10-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Vinflunin\nTopic: Third-line chemotherapy and disease progression\n\n[Context 4]\nContent: Mr. Peter Rudolph's chemotherapy with Gemcitabine/Cisplatin from April to July 2019 was well-tolerated.\nTime: 2019-04-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Gemcitabine, Cisplatin\nTopic: Chemotherapy tolerance\n\n[Context 5]\nContent: The indication exists for initiating second-line therapy with an immune checkpoint inhibitor (Pembrolizumab, Atezolizumab, or Nivolumab) for Mr. Peter Rudolph.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Pembrolizumab, Atezolizumab, Nivolumab\nTopic: Second-line therapy recommendation\n\n[Context 6]\nContent: If immune checkpoint inhibitor therapy is not feasible for Mr. Peter Rudolph, re-induction with Gemcitabine/Cisplatin or alternative therapy with Vinflunine as second-line treatment should be considered.\nPersons: Peter Rudolph\nRelated Entities: Gemcitabine, Cisplatin, Vinflunine\nTopic: Alternative therapy options\n\n[Context 7]\nContent: Mr. Peter Rudolph received four cycles of adjuvant chemotherapy with Gemcitabine and Cisplatin from April 2019 to July 2019.\nTime: 2019-04-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Gemcitabine, Cisplatin\nTopic: Cancer chemotherapy treatment\n\n[Context 8]\nContent: Mr. Peter Rudolph received four cycles of adjuvant chemotherapy with Gemcitabine/Cisplatin from 2019-04-19 to 2019-07-19.\nTime: 2019-04-19T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Gemcitabine, Cisplatin\nTopic: Chemotherapy treatment\n\n[Context 9]\nContent: From April 2019 to July 2019, Mr. Peter Rudolph received four cycles of adjuvant chemotherapy with Gemcitabine and Cisplatin.\nTime: 2019-04-01T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Gemcitabine, Cisplatin\nTopic: Chemotherapy treatment\n\n[Context 10]\nContent: Mr. Peter Rudolph expressed a tendency toward watchful waiting due to significant side effects from prior third-line chemotherapy with Vinflunin, and no final decision was made among the proposed alternatives during the consultation on 2021-06-29.\nTime: 2021-06-29T00:00:00\nPersons: Peter Rudolph\nRelated Entities: Vinflunin\nTopic: Patient preference and decision-making\n\n[Context 11]\nContent: Mr. Peter Rudolph, born on 1954-05-26, was under treatment at an outpatient clinic on 2020-04-20.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nTopic: Patient outpatient visit\n\n[Context 12]\nContent: Mr. Peter Rudolph is well-connected to his outpatient oncologist and has a long commute; local therapy initiation was discussed with him.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nTopic: Therapy logistics discussion\n\n[Context 13]\nContent: In January 2021, a molecular tumor board found no evidence of a molecular target in Mr. Peter Rudolph's case.\nTime: 2021-01-01T00:00:00\nPersons: Peter Rudolph\nTopic: Molecular tumor board evaluation\n\n[Context 14]\nContent: Mr. Peter Rudolph presented electively in the urological clinic for a CT-guided liver biopsy to evaluate further therapy due to significant disease progression under Nivolumab immunotherapy.\nLocation: urological clinic\nPersons: Peter Rudolph\nRelated Entities: Nivolumab\nTopic: Clinical presentation and rationale for biopsy\n\n[Context 15]\nContent: If systemic therapy with an immune checkpoint inhibitor is initiated despite existing rheumatic symptoms in Mr. Peter Rudolph, regular follow-up and close clinical monitoring are recommended.\nPersons: Peter Rudolph\nTopic: Monitoring during immunotherapy\n\n[Context 16]\nContent: Mr. Peter Rudolph was strongly advised to consult a rheumatologist before initiating systemic therapy with an immune checkpoint inhibitor.\nTime: 2020-04-20T00:00:00\nPersons: Peter Rudolph\nTopic: Pre-therapy specialist referral\n\n[Context 17]\nContent: In the event of acute complications or side effects during immune checkpoint inhibitor therapy, Mr. Peter Rudolph may require immediate medical evaluation and timely high-dose cortisone therapy with Prednisolone if the side effect is immune-associated.\nPersons: Peter Rudolph\nRelated Entities: Prednisolone\nTopic: Management of immunotherapy complications\n\n[Context 18]\nContent: In April 2020, Mr. Peter Rudolph was initially diagnosed with liver metastases in Segment 6 and Segment 7.\nTime: 2020-04-01T00:00:00\nPersons: Peter Rudolph\nTopic: Metastasis diagnosis\n\n[Context 19]\nContent: Prior to initiating systemic therapy with an immune checkpoint inhibitor, consultation with a local rheumatologist is recommended for Mr. Peter Rudolph to evaluate rheumatic symptoms.\nPersons: Peter Rudolph\nTopic: Pre-therapy evaluation recommendation\n\n[Context 20]\nContent: Mr. Peter Rudolph was found to have newly emerged liver metastasis in Segment 6 and Segment 7 in April 2020.\nTime: 2020-04-01T00:00:00\nPersons: Peter Rudolph\nTopic: Cancer progression\n\nQuestion:\nWhich immunotherapy was Mr. Rudolph administered from May to September 2020?\n\nOptions:\nA. Pembrolizumab\nB. Atezolizumab\nC. Ipilimumab\nD. Nivolumab\nE. Durvalumab\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: D",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: D",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804845,
+      "id": "chatcmpl-de8f707b-0119-991d-b138-9a1bd52d57a1",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1824,
+        "total_tokens": 1828
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c08e261941a54924.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c08e261941a54924",
+  "timestamp": "2026-04-10T06:45:45.128133+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Regarding Paul Doe, what was the histological size of the metastatic recurrence from the previously known hypopharyngeal carcinoma?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Paul Doe\", \"histological size\", \"metastatic recurrence\", \"hypopharyngeal carcinoma\"],\n  \"persons\": [\"Paul Doe\"],\n  \"time_expression\": \"previously known\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Paul Doe\", \"histological size\", \"metastatic recurrence\", \"hypopharyngeal carcinoma\"],\n  \"persons\": [\"Paul Doe\"],\n  \"time_expression\": \"previously known\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803542,
+      "id": "chatcmpl-5d346768-ad51-9be6-b034-538294ab16f9",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 62,
+        "prompt_tokens": 197,
+        "total_tokens": 259
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c0acbc98175036d9.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c0acbc98175036d9",
+  "timestamp": "2026-04-10T06:45:29.425796+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which of the following is NOT one of the patient's diagnoses?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"patient\", \"diagnoses\"],\n  \"persons\": [],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"patient\", \"diagnoses\"],\n  \"persons\": [],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803527,
+      "id": "chatcmpl-db2e2214-3032-9b58-87e6-247bb231fe3e",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 41,
+        "prompt_tokens": 184,
+        "total_tokens": 225
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c0f38f7fd7f63411.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c0f38f7fd7f63411",
+  "timestamp": "2026-04-10T06:42:24.685493+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Based on the clinical history of Mr. John Williams, which of the following statements is accurate?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"clinical history\", \"Mr. John Williams\", \"accurate\", \"statements\"],\n  \"persons\": [\"John Williams\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"clinical history\", \"Mr. John Williams\", \"accurate\", \"statements\"],\n  \"persons\": [\"John Williams\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803342,
+      "id": "chatcmpl-744a8230-42a0-9707-86fd-790fadc159e1",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 53,
+        "prompt_tokens": 190,
+        "total_tokens": 243
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c11ec6e82d220914.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c11ec6e82d220914",
+  "timestamp": "2026-04-10T06:43:06.064160+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Regarding her pancreatic condition, which procedure was Mrs. Anderson subjected to on 09/29/21?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"pancreatic condition\", \"procedure\", \"Mrs. Anderson\"],\n  \"persons\": [\"Mrs. Anderson\"],\n  \"time_expression\": \"09/29/21\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"pancreatic condition\", \"procedure\", \"Mrs. Anderson\"],\n  \"persons\": [\"Mrs. Anderson\"],\n  \"time_expression\": \"09/29/21\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803383,
+      "id": "chatcmpl-9b74c32b-31ea-971c-8c7b-56e331c9e7f2",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 59,
+        "prompt_tokens": 195,
+        "total_tokens": 254
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c12a6025c267f181.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c12a6025c267f181",
+  "timestamp": "2026-04-10T06:46:17.247435+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What was the date when Mr. Doe presented to the outpatient clinic for phoniatrics and pedaudiology?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mr. Doe\", \"outpatient clinic\", \"phoniatrics\", \"pedaudiology\"],\n  \"persons\": [\"Mr. Doe\"],\n  \"time_expression\": null,\n  \"location\": \"outpatient clinic\",\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mr. Doe\", \"outpatient clinic\", \"phoniatrics\", \"pedaudiology\"],\n  \"persons\": [\"Mr. Doe\"],\n  \"time_expression\": null,\n  \"location\": \"outpatient clinic\",\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803574,
+      "id": "chatcmpl-50cb1a1b-e3ce-94eb-b94e-6c65f324e53f",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 59,
+        "prompt_tokens": 192,
+        "total_tokens": 251
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c1e01685724234a9.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c1e01685724234a9",
+  "timestamp": "2026-04-10T07:09:45.622789+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_16",
+    "question_id": 17,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mr. John Chapman has a history of aspiration pneumonia.\nPersons: John Chapman\nTopic: Pulmonary infection history\n\n[Context 2]\nContent: Mr. John Chapman was diagnosed with aspiration pneumonia.\nPersons: John Chapman\nTopic: Aspiration pneumonia diagnosis\n\n[Context 3]\nContent: The neurology assessment on 2017-04-06 concluded that Mr. John Chapman required long-term ventilation due to intracerebral bleeding and skull base fracture, and showed no response to pain stimuli or pupillary light reactions.\nTime: 2017-04-06T00:00:00\nTopic: Neurology assessment and ventilation indication\n\n[Context 4]\nContent: Reduction of sedation in Mr. John Chapman was discontinued due to increased intracranial pressure.\nPersons: Mr. John Chapman\nTopic: Intracranial pressure management complication\n\n[Context 5]\nContent: On 2017-04-03, Mr. John Chapman was diagnosed with aspiration pneumonia.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Aspiration pneumonia diagnosis\n\n[Context 6]\nContent: On 2017-04-16, Mr. John Chapman was in the process of weaning from mechanical ventilation and was breathing spontaneously with intermittent CPAP support.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Ventilator weaning status\n\n[Context 7]\nContent: At the time of admission on 2017-04-03, Mr. John Chapman was hemodynamically stable.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Hemodynamic stability on admission\n\n[Context 8]\nContent: Mr. John Chapman, born on 1994-11-16, was admitted to the Intensive Care Unit from 2017-04-03 to 2017-05-01.\nPersons: John Chapman\nTopic: ICU admission period\n\n[Context 9]\nContent: An external ventricular drain was placed in Mr. John Chapman following admission to manage intracranial pressure.\nTime: 2017-04-03\nPersons: Mr. John Chapman\nTopic: Neurosurgical intervention\n\n[Context 10]\nContent: At the time of admission on 2017-04-03, Mr. John Chapman was intubated and sedated with a Richmond Agitation-Sedation Scale (RASS) score of -4.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Patient sedation status on admission\n\n[Context 11]\nContent: On 2017-04-16, Mr. John Chapman had sufficient renal function and was receiving enteral nutrition via PEG with supplemental parenteral nutrition that was successful.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Nutritional and renal status\n\n[Context 12]\nContent: Upon admission on 2017-04-03, Mr. John Chapman was sedated and intubated with a Richmond Agitation-Sedation Scale (RASS) score of -4 and was hemodynamically stable under controlled ventilation.\nTime: 2017-04-03\nPersons: Mr. John Chapman\nTopic: Admission clinical status\n\n[Context 13]\nContent: Due to persistently elevated intracranial pressure, Mr. John Chapman was started on intensive intracranial pressure therapy involving deeper sedation and administration of unspecified agents.\nPersons: Mr. John Chapman\nTopic: Intracranial pressure therapeutic escalation\n\n[Context 14]\nContent: Mr. John Chapman was intubated at the scene of the motocross accident, and aspiration occurred either during or before intubation.\nTime: 2017-04-03\nLocation: scene of accident\nPersons: Mr. John Chapman\nTopic: Pre-hospital airway management and complication\n\n[Context 15]\nContent: Mr. John Chapman was suspected of having Propofol infusion syndrome.\nPersons: John Chapman\nTopic: Medication complication suspicion\n\n[Context 16]\nContent: Mr. John Chapman was diagnosed with rhabdomyolysis.\nPersons: John Chapman\nTopic: Rhabdomyolysis diagnosis\n\n[Context 17]\nContent: During or before intubation at the scene of the motocross accident, Mr. John Chapman experienced aspiration.\nLocation: scene of motocross accident\nPersons: John Chapman\nTopic: Aspiration during pre-hospital care\n\n[Context 18]\nContent: On 2017-04-16, Mr. John Chapman had stable circulation without requiring catecholamine therapy.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Cardiovascular status\n\n[Context 19]\nContent: During the neurology consultation on 2017-04-06, Mr. John Chapman was found to be comatose, intubated, and sedated, with isocoric pupils, absent light reaction in both eyes, no response to pain stimuli for vestibulo-ocular reflex and oculomotor responses, and a negative Babinski reflex.\nTime: 2017-04-06T00:00:00\nTopic: Neurological examination findings\n\n[Context 20]\nContent: On 2017-04-08, Mr. John Chapman underwent placement of an intracranial pressure monitoring catheter.\nTime: 2017-04-08T00:00:00\nPersons: John Chapman\nTopic: Surgical procedure - ICP monitoring catheter\n\n[Context 21]\nContent: Mr. John Chapman was pre-admitted on 2019-05-24 due to medically justified increased risk for digital subtraction angiography of intracranial vessels.\nTime: 2019-05-24\nPersons: John Chapman\nTopic: Pre-procedure admission\n\n[Context 22]\nContent: Mr. John Chapman had a history of appendectomy in 2006.\nTime: 2006-01-01T00:00:00\nPersons: John Chapman\nTopic: Past medical history - appendectomy\n\n[Context 23]\nContent: On 2017-05-01, Mr. John Chapman underwent left ventriculoperitoneal shunt placement.\nTime: 2017-05-01T00:00:00\nPersons: John Chapman\nTopic: Surgical procedure - VP shunt placement\n\n[Context 24]\nContent: On an unspecified date during the ICU stay, coagulation studies showed Quick value of 54% (reference range: 78–123%), international normalized ratio (INR) of 1.36 (reference range: 0.90–1.25), and activated partial thromboplastin time (aPTT) of 32.8 seconds (reference range: 25.0–38.0 seconds).\nTopic: Coagulation profile\n\n[Context 25]\nContent: On an unspecified date during the ICU stay, laboratory results showed hemoglobin of 7.6 g/dL (reference range: 13.5–17.0 g/dL), hematocrit of 28% (reference range: 39.5–50.5%), red blood cells of 3.5 million per microliter (reference range: 4.3–5.8 million per microliter), white blood cells of 10.35 thousand per microliter (reference range: 3.90–10.50 thousand per microliter), platelets of 379 thousand per microliter (reference range: 150–370 thousand per microliter), mean corpuscular volume (MCV) of 77.2 femtoliters (reference range: 80.0–99.0 fL), mean corpuscular hemoglobin (MCH) of 24.1 picograms (reference range: 27.0–33.5 pg), mean corpuscular hemoglobin concentration (MCHC) of 32.5 g/dL (reference range: 31.5–36.0 g/dL), mean platelet volume (MPV) of 11.3 fL (reference range: 7.0–12.0 fL), and red cell distribution width coefficient of variation (RDW-CV) of 17.7% (reference range: 11.5–15.0%).\nTopic: Complete blood count with indices\n\nQuestion:\nWhich complication did Mr. Chapman NOT experience during his ICU stay?\n\nOptions:\nA. Rhabdomyolysis\nB. Diabetes insipidus\nC. Malresorptive hydrocephalus\nD. Infarct areas in the MCA-ACA border zones\nE. Subarachnoid hemorrhage\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804984,
+      "id": "chatcmpl-0c2f233e-fdf3-9690-9da2-dca97209287e",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2176,
+        "total_tokens": 2180
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c29567e7ca8908f0.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c29567e7ca8908f0",
+  "timestamp": "2026-04-10T07:10:58.769269+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_19",
+    "question_id": 17,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Upon discharge, Emil Nilsson's calcium level was 2.54 mEq/L (reference range: 2.10-2.55 mEq/L).\nPersons: Emil Nilsson\nTopic: Discharge laboratory results\n\n[Context 2]\nContent: At discharge, Emil Nilsson's calcium level was 2.33 mEq/L within reference range 2.10-2.55 mEq/L.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 3]\nContent: Upon discharge, Emil Nilsson's phosphate level was 1.42 mEq/L (reference range: 0.84-1.45 mEq/L).\nPersons: Emil Nilsson\nTopic: Discharge laboratory results\n\n[Context 4]\nContent: Emil Nilsson received physiotherapy during hospitalization, and his general condition improved daily.\nPersons: Emil Nilsson\nTopic: Rehabilitation and recovery\n\n[Context 5]\nContent: Emil Nilsson's blood pressures changed only slightly after medication adjustment.\nPersons: Emil Nilsson\nTopic: Treatment response\n\n[Context 6]\nContent: At discharge, Emil Nilsson's phosphorus level was 1.12 mEq/L within reference range 0.84-1.45 mEq/L.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 7]\nContent: Upon discharge, Emil Nilsson's magnesium level was 0.61 mEq/L (reference range: 0.62-0.91 mEq/L).\nPersons: Emil Nilsson\nTopic: Discharge laboratory results\n\n[Context 8]\nContent: At discharge, Emil Nilsson's magnesium level was 1.84 mg/dL within reference range 1.5-2.3 mg/dL.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 9]\nContent: Upon discharge, Emil Nilsson's iron level was 20.6 µmol/L (reference range: 4.8-24.7 µmol/L).\nPersons: Emil Nilsson\nTopic: Discharge laboratory results\n\n[Context 10]\nContent: Emil Nilsson was prescribed vitamin D supplementation upon discharge.\nPersons: Emil Nilsson\nTopic: Discharge medication - vitamin D\n\n[Context 11]\nContent: Emil Nilsson had percutaneous oxygen saturation of 76% at the time of admission.\nTime: 2008-03-01\nPersons: Emil Nilsson\nTopic: Oxygen saturation measurement\n\n[Context 12]\nContent: During treatment from 2005-01-26 to 2005-02-02, Emil Nilsson had temporary diarrhea that was managed with adequate fluid substitution.\nTime: 2005-01-26T00:00:00\nPersons: Emil Nilsson\nTopic: Gastrointestinal side effect management\n\n[Context 13]\nContent: Emil Nilsson weighed 12.4 kg and had a body length of 93 cm at the time of admission.\nTime: 2008-03-01\nPersons: Emil Nilsson\nTopic: Anthropometric measurements\n\n[Context 14]\nContent: At discharge, Emil Nilsson's iron level was 20.4 µg/dL within reference range 4.8-24.7 µg/dL.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 15]\nContent: Emil Nilsson's blood pressure upon admission was: right upper arm 124/60 mmHg, left upper arm 112/59 mmHg, right lower leg 134/55 mmHg, left lower leg 146/71 mmHg.\nPersons: Emil Nilsson\nTopic: Blood pressure measurements\n\n[Context 16]\nContent: Emil Nilsson showed satisfactory weight gain during the period leading up to the inpatient stay from 2005-01-26 to 2005-02-02.\nTime: 2005-01-26T00:00:00\nPersons: Emil Nilsson\nTopic: Growth and development\n\n[Context 17]\nContent: IV antibiotics for Emil Nilsson were continued until 2005-01-22.\nTime: 2005-01-22\nPersons: Emil Nilsson\nTopic: Antibiotic therapy\n\n[Context 18]\nContent: Emil Nilsson had percutaneous oxygen saturation of 77% upon admission.\nPersons: Emil Nilsson\nTopic: Oxygen saturation measurement\n\n[Context 19]\nContent: Emil Nilsson had transcutaneous oxygen saturation of 85%.\nPersons: Emil Nilsson\nTopic: Oxygenation status\n\n[Context 20]\nContent: At discharge, Emil Nilsson's transferrin was 2.89 g/L.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 21]\nContent: Upon discharge, Emil Nilsson's transferrin was 2.89 g/L.\nPersons: Emil Nilsson\nTopic: Discharge laboratory results\n\n[Context 22]\nContent: Emil Nilsson had normal stool during the inpatient stay.\nPersons: Emil Nilsson\nTopic: Gastrointestinal status\n\n[Context 23]\nContent: Emil Nilsson's lab results show calcium at 2.38 mEq/L (reference range: 2.10–2.55 mEq/L), phosphate at 1.19 mEq/L (reference range: 0.84–1.45 mEq/L), osmolality at 282 mOsm/kg (reference range: 280–300 mOsm/kg), iron at 20.0 µg/dL (reference range: 4.8–24.7 µg/dL), transferrin saturation at 28.1% (reference range: 16.0–45.0%), magnesium at 0.79 mEq/L (reference range: 0.62–0.91 mEq/L), creatinine at 0.81 mg/dL (reference range: 0.70–1.20 mg/dL), estimated GFR (CKD-EPI) at 131 mL/min, estimated GFR (Cystatin) greater than 90.0 mL/min, urea (BUN) at 27 mg/dL (reference range: 18–45 mg/dL), total bilirubin at 0.92 mg/dL (reference range: <1.20 mg/dL), and direct bilirubin at 0.38 mg/dL (reference range: <0.30 mg/dL).\nPersons: Emil Nilsson\nTopic: Comprehensive metabolic and renal function laboratory results\n\n[Context 24]\nContent: At discharge, Emil Nilsson's triglycerides were 64 mg/dL.\nTime: 2008-03-03\nPersons: Emil Nilsson\nTopic: Laboratory test result\n\n[Context 25]\nContent: Initial neurological examination of Emil Nilsson was unremarkable.\nTime: 2008-03-01\nPersons: Emil Nilsson\nTopic: Neurological examination\n\nQuestion:\nHow did Mr. Nilsson's calcium levels develop over the course of time?\n\nOptions:\nA. Lower in July 2008 than in October 2021.\nB. Highest in July 2008\nC. Identical at several time points\nD. Only recorded in October 2021.\nE. Outside the reference range in both instances.\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775805057,
+      "id": "chatcmpl-09b9efb2-2f1c-99b6-bb9a-41fdd46c838d",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1860,
+        "total_tokens": 1864
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c2b711e63ba548aa.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c2b711e63ba548aa",
+  "timestamp": "2026-04-10T06:41:33.579766+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Following Mrs. Done's microsurgical resection on 01/02/2020, what did the MRI brain report dated 01/04/2020 primarily indicate about the surgical site?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"microsurgical resection\", \"MRI brain report\", \"surgical site\"],\n  \"persons\": [\"Mrs. Done\"],\n  \"time_expression\": \"01/04/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"microsurgical resection\", \"MRI brain report\", \"surgical site\"],\n  \"persons\": [\"Mrs. Done\"],\n  \"time_expression\": \"01/04/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803290,
+      "id": "chatcmpl-48eb4388-9ac6-9b8e-ac8f-a209d4a22fdc",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 64,
+        "prompt_tokens": 219,
+        "total_tokens": 283
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c369a0e126ce9d18.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c369a0e126ce9d18",
+  "timestamp": "2026-04-10T06:48:34.292168+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: On what date was a CT scan of the chest/abdomen/pelvis with contrast agent performed in Laura Miller?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"CT scan\", \"chest\", \"abdomen\", \"pelvis\", \"contrast agent\"],\n  \"persons\": [\"Laura Miller\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"CT scan\", \"chest\", \"abdomen\", \"pelvis\", \"contrast agent\"],\n  \"persons\": [\"Laura Miller\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803711,
+      "id": "chatcmpl-eb05b20b-fa32-983d-a341-de23dbf6066e",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 56,
+        "prompt_tokens": 196,
+        "total_tokens": 252
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c387be74931aaa93.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c387be74931aaa93",
+  "timestamp": "2026-04-10T07:02:37.743511+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: In 2019, what treatment was continued for Mrs. Sanders despite gastrointestinal issues?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"treatment\", \"gastrointestinal issues\"],\n  \"persons\": [\"Mrs. Sanders\"],\n  \"time_expression\": \"2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"treatment\", \"gastrointestinal issues\"],\n  \"persons\": [\"Mrs. Sanders\"],\n  \"time_expression\": \"2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804555,
+      "id": "chatcmpl-cf56a155-a0f8-9944-93b6-4edf5106792d",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 51,
+        "prompt_tokens": 190,
+        "total_tokens": 241
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c461a046efc2fcb9.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c461a046efc2fcb9",
+  "timestamp": "2026-04-10T06:43:18.431775+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What was the histopathological finding related to the gallbladder during the exploratory laparotomy performed in Mrs. Anderson?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"histopathological finding\", \"gallbladder\", \"exploratory laparotomy\"],\n  \"persons\": [\"Mrs. Anderson\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"histopathological finding\", \"gallbladder\", \"exploratory laparotomy\"],\n  \"persons\": [\"Mrs. Anderson\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803395,
+      "id": "chatcmpl-3ec5deca-2dd9-996b-be38-db8f4d479b82",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 57,
+        "prompt_tokens": 197,
+        "total_tokens": 254
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c4e86af6ca023960.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c4e86af6ca023960",
+  "timestamp": "2026-04-10T07:06:59.479409+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_09",
+    "question_id": 16,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: The Liver Tumor Board made a decision on 2019-08-18 to recommend systemic therapy for Paul Wells.\nTime: 2019-08-18T00:00:00\nPersons: Paul Wells\nRelated Entities: Liver Tumor Board\nTopic: Liver Tumor Board recommendation\n\n[Context 2]\nContent: The interdisciplinary liver tumor board recommended systemic therapy for Paul Wells.\nPersons: Paul Wells\nRelated Entities: interdisciplinary liver tumor board\nTopic: Multidisciplinary treatment recommendation\n\n[Context 3]\nContent: The Liver Tumor Board decided on 2019-08-18 that Paul Wells should receive systemic therapy for hepatocellular carcinoma.\nTime: 2019-08-18T00:00:00\nPersons: Paul Wells\nRelated Entities: Liver Tumor Board\nTopic: Treatment decision by tumor board\n\n[Context 4]\nContent: On 2019-08-18, the Liver Tumor Board decided that Paul Wells should receive systemic therapy for hepatocellular carcinoma.\nTime: 2019-08-18\nPersons: Paul Wells\nRelated Entities: Liver Tumor Board\nTopic: Treatment decision by tumor board\n\n[Context 5]\nContent: The liver board recommended liver puncture, staging, and endoscopic exclusion of a gastrointestinal primary tumor for Mr. Paul Wells.\nPersons: Paul Wells\nTopic: Diagnostic recommendations\n\n[Context 6]\nContent: An interdisciplinary conference on or before 2020-08-14 recommended systemic therapy for Paul Wells after determining SIRT was not suitable.\nTime: 2020-08-14T00:00:00\nPersons: Paul Wells\nTopic: Therapeutic recommendation after multidisciplinary review\n\n[Context 7]\nContent: As of the 2020-11-20 follow-up, Paul Wells' hepatocellular carcinoma remained stable with no significant progression or new metastases.\nTime: 2020-11-20T00:00:00\nPersons: Paul Wells\nTopic: Overall oncological assessment\n\n[Context 8]\nContent: The Liver Board reached a consensus to admit Paul Wells for selective internal radiation therapy (SIRT) simulation.\nPersons: Paul Wells\nRelated Entities: Liver Board\nTopic: Treatment planning decision\n\n[Context 9]\nContent: A follow-up evaluation for Paul Wells through liver MRI and CT was scheduled for 2020-01-04 at the HCC clinic.\nTime: 2020-01-04T00:00:00\nLocation: HCC clinic\nPersons: Paul Wells\nRelated Entities: HCC clinic\nTopic: Scheduled imaging follow-up\n\n[Context 10]\nContent: Mr. Paul Wells presented electively for further diagnostics of multiple malignoma-specific hepatic space-occupying lesions as decided by the interdisciplinary liver board on 2019-07-20.\nTime: 2019-07-20T00:00:00\nPersons: Paul Wells\nTopic: Referral and diagnostic plan\n\n[Context 11]\nContent: On 2020-11-20 at 12:45 PM, Paul Wells underwent a contrast-enhanced CT scan of the chest, abdomen, and pelvis, which showed stable known liver lesions and no evidence of malignancy or metastasis elsewhere.\nTime: 2020-11-20T12:45:00\nPersons: Paul Wells\nTopic: Thoracoabdominal CT findings\n\n[Context 12]\nContent: Mr. Paul Wells was diagnosed with suspected multifocal hepatocellular carcinoma (HCC) in liver segments IV, VII/VIII, first diagnosed on 2019-07-19.\nTime: 2019-07-19T00:00:00\nPersons: Paul Wells\nTopic: Cancer diagnosis\n\n[Context 13]\nContent: On 2020-11-20 at 09:01 AM, Paul Wells underwent an MRI of the liver with plain and contrast imaging, which revealed stable HCC lesions in segments IV and VII/VIII with no new lesions or metastases.\nTime: 2020-11-20T09:01:00\nPersons: Paul Wells\nTopic: Liver MRI findings\n\n[Context 14]\nContent: On 2019-07-26 at 10:15 AM, Mr. Paul Wells underwent ultrasound-guided liver puncture in segment IV for suspected metastatic liver malignancy.\nTime: 2019-07-26T10:15:00\nPersons: Paul Wells\nTopic: Liver biopsy procedure\n\n[Context 15]\nContent: Tumor marker diagnostics for Mr. Paul Wells were inconclusive.\nPersons: Paul Wells\nTopic: Laboratory diagnostics\n\n[Context 16]\nContent: Staging examinations in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Tumor staging result\n\n[Context 17]\nContent: Short-term follow-up CT staging in Paul Wells showed a known, size-stable, hypervascularized hepatic lesion in both liver lobes, with no evidence of other thoracoabdominal malignancies or suspicious lymph nodes.\nPersons: Paul Wells\nTopic: Follow-up CT staging results\n\n[Context 18]\nContent: Paul Wells was diagnosed with multifocal hepatocellular carcinoma (HCC) in the liver segment with portal vein invasion, classified as BCLC stage C, first diagnosed on 2019-07-19.\nTime: 2019-07-19T00:00:00\nPersons: Paul Wells\nTopic: Hepatocellular carcinoma diagnosis\n\n[Context 19]\nContent: Histology performed on 2019-07-27 confirmed well-differentiated hepatocellular carcinoma (G1) with macrotrabecular and pseudoglandular growth pattern in Paul Wells.\nTime: 2019-07-27T00:00:00\nPersons: Paul Wells\nTopic: Histopathological diagnosis\n\n[Context 20]\nContent: Paul Wells was diagnosed with multifocal hepatocellular carcinoma (HCC) involving liver segments IV, VII/VIII, with portal vein invasion, classified as BCLC stage C, and the diagnosis was made in July 2019.\nTime: 2019-07-01T00:00:00\nPersons: Paul Wells\nTopic: Hepatocellular carcinoma diagnosis details\n\n[Context 21]\nContent: Computer tomography of Mr. Paul Wells showed multiple intrahepatic masses in the right liver lobe (segments IV, VII/VIII).\nPersons: Paul Wells\nTopic: Imaging findings\n\n[Context 22]\nContent: A CT scan in July 2019 showed multiple intrahepatic lesions in the right liver lobe (segments SIV, SVII/VIII) in Paul Wells.\nTime: 2019-07-01T00:00:00\nPersons: Paul Wells\nTopic: Initial imaging findings\n\nQuestion:\nWhen was the liver tumor board decision for systemic therapy made for Mr. Wells?\n\nOptions:\nA. 07/20/2019\nB. 08/18/2019\nC. 01/01/2020\nD. 08/24/2019\nE. 07/27/2019\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804818,
+      "id": "chatcmpl-71df72a6-3c32-9336-80e7-9c9d4d43f212",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1825,
+        "total_tokens": 1829
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c50422dbcd9def72.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c50422dbcd9def72",
+  "timestamp": "2026-04-10T07:03:37.180613+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_01",
+    "question_id": 9,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: On admission, Mrs. Anna Sample's medication included Lorazepam 1mg as needed.\nPersons: Anna Sample\nRelated Entities: Lorazepam, Tavor\nTopic: Medication list on admission\n\n[Context 2]\nContent: On admission, Mrs. Anna Sample's medication included Aspirin 100mg once daily in the morning.\nPersons: Anna Sample\nRelated Entities: Aspirin\nTopic: Medication list on admission\n\n[Context 3]\nContent: On admission, Mrs. Anna Sample's medication included Hydromorphone hydrochloride 2mg extended-release, two capsules in the morning and two at bedtime.\nPersons: Anna Sample\nRelated Entities: Hydromorphone hydrochloride\nTopic: Medication list on admission\n\n[Context 4]\nContent: Medication at discharge for Mrs. Anna Sample included Hydromorphone hydrochloride 2mg extended-release, two capsules in the morning and two at bedtime.\nPersons: Anna Sample\nRelated Entities: Hydromorphone hydrochloride\nTopic: Discharge medication list\n\n[Context 5]\nContent: On admission, Mrs. Anna Sample's medication included Prednisolone 50mg twice daily in the morning, to continue through 2017-02-19.\nTime: 2017-02-19T00:00:00\nPersons: Anna Sample\nRelated Entities: Prednisolone\nTopic: Medication list on admission\n\n[Context 6]\nContent: Medication at discharge for Mrs. Anna Sample included Aspirin 100mg once daily in the morning.\nPersons: Anna Sample\nRelated Entities: Aspirin\nTopic: Discharge medication list\n\n[Context 7]\nContent: Medication at discharge for Mrs. Anna Sample included Lorazepam 1mg as needed.\nPersons: Anna Sample\nRelated Entities: Lorazepam, Tavor\nTopic: Discharge medication list\n\n[Context 8]\nContent: On admission, Mrs. Anna Sample's medication included Baclofen 10mg three times daily.\nPersons: Anna Sample\nRelated Entities: Baclofen, Lioresal\nTopic: Medication list on admission\n\n[Context 9]\nContent: Mrs. Sample had a urinary catheter in place at the time of documentation.\nPersons: Mrs. Sample\nTopic: Urinary catheter status\n\n[Context 10]\nContent: On admission, Mrs. Anna Sample's medication included Sertraline 50mg twice daily in the morning.\nPersons: Anna Sample\nRelated Entities: Sertraline\nTopic: Medication list on admission\n\n[Context 11]\nContent: On admission, Mrs. Anna Sample's medication included Pregabalin 75mg once in the morning and once at bedtime.\nPersons: Anna Sample\nRelated Entities: Pregabalin\nTopic: Medication list on admission\n\n[Context 12]\nContent: Medication at discharge for Mrs. Anna Sample included MoviCOL one packet three times daily mixed with water.\nPersons: Anna Sample\nRelated Entities: MoviCOL\nTopic: Discharge medication list\n\n[Context 13]\nContent: Mrs. Sample reported a weight loss of 5 kg during her hospitalization.\nPersons: Mrs. Sample\nTopic: Weight change during hospital stay\n\n[Context 14]\nContent: Medication at discharge for Mrs. Anna Sample included Pregabalin 75mg once in the morning and once at bedtime.\nPersons: Anna Sample\nRelated Entities: Pregabalin\nTopic: Discharge medication list\n\n[Context 15]\nContent: Medication at discharge for Mrs. Anna Sample included Baclofen 10mg three times daily.\nPersons: Anna Sample\nRelated Entities: Baclofen, Lioresal\nTopic: Discharge medication list\n\n[Context 16]\nContent: Medication at discharge for Mrs. Anna Sample included Sertraline 50mg twice daily in the morning.\nPersons: Anna Sample\nRelated Entities: Sertraline\nTopic: Discharge medication list\n\n[Context 17]\nContent: On admission, Mrs. Anna Sample's medication included Pantoprazole 40mg once daily in the morning.\nPersons: Anna Sample\nRelated Entities: Pantoprazole\nTopic: Medication list on admission\n\n[Context 18]\nContent: Medication at discharge for Mrs. Anna Sample included Melatonin 2mg sustained-release once daily at bedtime.\nPersons: Anna Sample\nRelated Entities: Melatonin\nTopic: Discharge medication list\n\n[Context 19]\nContent: On admission, Mrs. Anna Sample's medication included Co-trimoxazole 960mg on Mondays, Wednesdays, and Fridays.\nPersons: Anna Sample\nRelated Entities: Co-trimoxazole\nTopic: Medication list on admission\n\n[Context 20]\nContent: On admission, Mrs. Anna Sample's medication included Enoxaparin sodium (Clexane) 40mg once daily at bedtime, to continue in case of immobility.\nPersons: Anna Sample\nRelated Entities: Enoxaparin sodium, Clexane\nTopic: Medication list on admission\n\n[Context 21]\nContent: Medication at discharge for Mrs. Anna Sample included Pantoprazole 40mg once daily in the morning.\nPersons: Anna Sample\nRelated Entities: Pantoprazole\nTopic: Discharge medication list\n\n[Context 22]\nContent: Medication at discharge for Mrs. Anna Sample included Dimenhydrinate 150mg sustained-release as needed for nausea, up to two capsules daily.\nPersons: Anna Sample\nRelated Entities: Dimenhydrinate, Vomex A\nTopic: Discharge medication list\n\n[Context 23]\nContent: On admission, the patient was taking Lorazepam (Ativan®) 1 mg as needed.\nRelated Entities: Ativan®\nTopic: Medications on admission\n\n[Context 24]\nContent: On admission, Mrs. Anna Sample's medication included Valaciclovir 500mg twice daily.\nPersons: Anna Sample\nRelated Entities: Valaciclovir\nTopic: Medication list on admission\n\n[Context 25]\nContent: On admission, Mrs. Anna Sample's medication included Atorvastatin 40mg once daily at bedtime.\nPersons: Anna Sample\nRelated Entities: Atorvastatin\nTopic: Medication list on admission\n\nQuestion:\nBased on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?\n\nOptions:\nA. The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.\nB. The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.\nC. The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.\nD. The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.\nE. The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: E",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: E",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804616,
+      "id": "chatcmpl-4052e8ff-5bfc-9c44-b1a2-d6f20be84c1c",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1624,
+        "total_tokens": 1628
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c56de0602c9059f9.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c56de0602c9059f9",
+  "timestamp": "2026-04-10T07:03:25.240879+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_01",
+    "question_id": 0,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mrs. Sample was transferred inpatient from DC for initiation of R-Pola-CHP chemotherapy for diffuse large B-cell lymphoma (DLBCL).\nLocation: DC\nPersons: Mrs. Sample\nTopic: Chemotherapy initiation and hospital transfer\n\n[Context 2]\nContent: Mrs. Anna Sample was diagnosed with Diffuse large B-cell lymphoma of germinal center type as of January 2017.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Oncologic diagnosis\n\n[Context 3]\nContent: Histopathology of Mrs. Anna Sample's tumor showed aggressive B-cell non-Hodgkin lymphoma (DLBCL, NOS) with no evidence of t(14;18) translocation, Ki-67 proliferation index of 40%, positive MUM1 immunoreactivity, numerous CD68-positive macrophages, and negative ALK1 and TdT immunoreactivity.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Lymphoma histopathology and immunophenotyping\n\n[Context 4]\nContent: PET/CT for Mrs. Anna Sample was performed on 2017-10-09 for follow-up evaluation of Diffuse large B-cell lymphoma of germinal center type diagnosed in January 2017.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: PET/CT indication\n\n[Context 5]\nContent: Because rituximab is an effective third-line therapy for multiple sclerosis and essential for treating DLBCL, discontinuation of fingolimod (a second-line MS therapy) was discussed with patient_01.\nRelated Entities: rituximab, fingolimod\nTopic: Immunomodulatory therapy management in comorbid MS and lymphoma\n\n[Context 6]\nContent: Mrs. S was admitted for chemotherapy with R-POLA-CHP regimen for suspected diffuse large B-cell lymphoma (DLBCL) with spinal/vertebral manifestations.\nPersons: Mrs. S\nTopic: Oncology admission reason\n\n[Context 7]\nContent: Bone marrow aspiration in Mrs. Anna Sample revealed no infiltration by lymphoma.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Bone marrow evaluation for lymphoma\n\n[Context 8]\nContent: The Ann-Arbor staging for Mrs. Anna Sample's lymphoma was Stage IV.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Lymphoma staging\n\n[Context 9]\nContent: As of 2017-10-09, the treating team intended to continue the current R-Pola-CHP regimen for Mrs. Anna Sample with careful monitoring of side effects and symptoms.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Treatment plan decision\n\n[Context 10]\nContent: On Day 1 of the R-Pola-CHP regimen, Mrs. Anna Sample received Polatuzumab vedotin at 1.8mg/kg.\nTime: 2017-01-01\nPersons: Anna Sample\nRelated Entities: Polatuzumab vedotin\nTopic: Chemotherapy drug administration\n\n[Context 11]\nContent: On Day 0 of the R-Pola-CHP regimen, Mrs. Anna Sample received Rituximab at 375mg/m².\nTime: 2017-01-01\nPersons: Anna Sample\nRelated Entities: Rituximab\nTopic: Chemotherapy drug administration\n\n[Context 12]\nContent: On Day 1 of the R-Pola-CHP regimen, Mrs. Anna Sample received Doxorubicin at 50mg/m².\nTime: 2017-01-01\nPersons: Anna Sample\nRelated Entities: Doxorubicin\nTopic: Chemotherapy drug administration\n\n[Context 13]\nContent: Physical examination of Mrs. Anna Sample on 2017-10-09 revealed no palpable lymphadenopathy.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Physical examination result\n\n[Context 14]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed no pathological FDG uptake in the previously noted left axillary lymph node.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Lymph node PET findings\n\n[Context 15]\nContent: On Day 1 of the R-Pola-CHP regimen, Mrs. Anna Sample received Cyclophosphamide at 750mg/m².\nTime: 2017-01-01\nPersons: Anna Sample\nRelated Entities: Cyclophosphamide\nTopic: Chemotherapy drug administration\n\n[Context 16]\nContent: Impression of PET/CT on 2017-10-09 for Mrs. Anna Sample demonstrated marked metabolic improvement in lymphoma sites but increased FDG avidity in liver requiring further evaluation.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: PET/CT clinical impression\n\n[Context 17]\nContent: Histology of the T10 epidural tumor resected from patient_01 on or before 2017-01-05 confirmed diffuse large B-cell lymphoma (DLBCL), leading to a chemotherapy plan including rituximab.\nTime: 2017-01-05T00:00:00\nRelated Entities: rituximab\nTopic: Pathological diagnosis and oncology treatment initiation\n\n[Context 18]\nContent: A CT scan of the chest, abdomen, and pelvis performed on 2016-12-24 in Mrs. Anna Sample showed an enlarged left axillary lymph node.\nTime: 2016-12-24\nPersons: Anna Sample\nTopic: Lymph node imaging finding\n\n[Context 19]\nContent: Mrs. Anna Sample had an R-IPI score of 2 based on elevated LDH and Stage IV disease.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Prognostic scoring in lymphoma\n\n[Context 20]\nContent: On admission, Mrs. Anna Sample's medication included Fingolimod 0.5mg once daily at bedtime with instructions to take a break as directed.\nPersons: Anna Sample\nRelated Entities: Fingolimod\nTopic: Medication list on admission\n\n[Context 21]\nContent: Mrs. Anna Sample began treatment with the R-Pola-CHP regimen on a 21-day cycle starting on 2017-01-01.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Initiation of lymphoma chemotherapy\n\n[Context 22]\nContent: The epidural tumor was morphologically and immunohistochemically classified as diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), of germinal center type according to the Hans classifier.\nRelated Entities: Hans classifier\nTopic: Lymphoma subtype classification\n\n[Context 23]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed no FDG uptake in the spine, including previously described metastatic lesion.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Bone PET findings\n\n[Context 24]\nContent: On 2016-12-19, Mrs. Sample presented with acute upper limb pain and restricted mobility in the context of pre-existing ALS.\nTime: 2016-12-19T00:00:00\nPersons: Mrs. Sample\nTopic: Symptom onset related to ALS and spinal pathology\n\n[Context 25]\nContent: On 2016-12-21, Mrs. Sample underwent surgical decompression at DC, which resulted in symptom relief.\nTime: 2016-12-21T00:00:00\nLocation: DC\nPersons: Mrs. Sample\nTopic: Surgical intervention for spinal compression\n\nQuestion:\nWhich of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?\n\nOptions:\nA. Polatuzumab vedotin\nB. Rituximab\nC. Cyclophosphamide\nD. Vincristine\nE. Doxorubicin\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: D",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: D",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804604,
+      "id": "chatcmpl-2633095a-9a93-9b7f-80f8-e0246baab01f",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2049,
+        "total_tokens": 2053
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c58445053852cd41.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c58445053852cd41",
+  "timestamp": "2026-04-10T07:09:44.661047+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_16",
+    "question_id": 16,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Reduction of sedation in Mr. John Chapman was discontinued due to increased intracranial pressure.\nPersons: Mr. John Chapman\nTopic: Intracranial pressure management complication\n\n[Context 2]\nContent: On 2017-04-16, Mr. John Chapman was in the process of weaning from mechanical ventilation and was breathing spontaneously with intermittent CPAP support.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Ventilator weaning status\n\n[Context 3]\nContent: At the time of admission on 2017-04-03, Mr. John Chapman was intubated and sedated with a Richmond Agitation-Sedation Scale (RASS) score of -4.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Patient sedation status on admission\n\n[Context 4]\nContent: Upon admission on 2017-04-03, Mr. John Chapman was sedated and intubated with a Richmond Agitation-Sedation Scale (RASS) score of -4 and was hemodynamically stable under controlled ventilation.\nTime: 2017-04-03\nPersons: Mr. John Chapman\nTopic: Admission clinical status\n\n[Context 5]\nContent: On 2017-04-16, Mr. John Chapman was monosedated with Clonidine, spontaneously opened both eyes, and moved all four extremities spontaneously.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Neurological status at transfer\n\n[Context 6]\nContent: Due to persistently elevated intracranial pressure, Mr. John Chapman was started on intensive intracranial pressure therapy involving deeper sedation and administration of unspecified agents.\nPersons: Mr. John Chapman\nTopic: Intracranial pressure therapeutic escalation\n\n[Context 7]\nContent: On 2017-04-16, Mr. John Chapman's medication regimen included Morphine Hydrochloride (MS Contin) 10 mg administered six times daily.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nRelated Entities: MS Contin\nTopic: Current medication\n\n[Context 8]\nContent: Mr. John Chapman was suspected of having Propofol infusion syndrome.\nPersons: John Chapman\nTopic: Medication complication suspicion\n\n[Context 9]\nContent: During the neurology consultation on 2017-04-06, Mr. John Chapman was found to be comatose, intubated, and sedated, with isocoric pupils, absent light reaction in both eyes, no response to pain stimuli for vestibulo-ocular reflex and oculomotor responses, and a negative Babinski reflex.\nTime: 2017-04-06T00:00:00\nTopic: Neurological examination findings\n\n[Context 10]\nContent: Mr. John Chapman was diagnosed with aspiration pneumonia.\nPersons: John Chapman\nTopic: Aspiration pneumonia diagnosis\n\n[Context 11]\nContent: On 2017-04-16, Mr. John Chapman had stable circulation without requiring catecholamine therapy.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Cardiovascular status\n\n[Context 12]\nContent: On 2017-04-03, Mr. John Chapman was diagnosed with aspiration pneumonia.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Aspiration pneumonia diagnosis\n\n[Context 13]\nContent: The neurology assessment on 2017-04-06 concluded that Mr. John Chapman required long-term ventilation due to intracerebral bleeding and skull base fracture, and showed no response to pain stimuli or pupillary light reactions.\nTime: 2017-04-06T00:00:00\nTopic: Neurology assessment and ventilation indication\n\n[Context 14]\nContent: At the time of admission on 2017-04-03, Mr. John Chapman was hemodynamically stable.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Hemodynamic stability on admission\n\n[Context 15]\nContent: Mr. John Chapman has a history of aspiration pneumonia.\nPersons: John Chapman\nTopic: Pulmonary infection history\n\n[Context 16]\nContent: On 2017-04-03, Mr. John Chapman underwent placement of an external ventricular drain.\nTime: 2017-04-03T00:00:00\nPersons: John Chapman\nTopic: Surgical procedure - external ventricular drain\n\n[Context 17]\nContent: On 2017-04-16, Mr. John Chapman had bilaterally moderately dilated, round pupils that were sensitive to light, and exhibited bulbar divergence.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Ocular and cranial nerve findings\n\n[Context 18]\nContent: On 2017-04-16, Mr. John Chapman's medication regimen included Acetaminophen (Tylenol) 1000 mg administered four times daily.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nRelated Entities: Tylenol\nTopic: Current medication\n\n[Context 19]\nContent: An external ventricular drain was placed in Mr. John Chapman following admission to manage intracranial pressure.\nTime: 2017-04-03\nPersons: Mr. John Chapman\nTopic: Neurosurgical intervention\n\n[Context 20]\nContent: During or before intubation at the scene of the motocross accident, Mr. John Chapman experienced aspiration.\nLocation: scene of motocross accident\nPersons: John Chapman\nTopic: Aspiration during pre-hospital care\n\n[Context 21]\nContent: Mr. John Chapman was diagnosed with abducens nerve palsy.\nPersons: John Chapman\nTopic: Neurological diagnosis\n\n[Context 22]\nContent: On 2017-04-16, Mr. John Chapman had sufficient renal function and was receiving enteral nutrition via PEG with supplemental parenteral nutrition that was successful.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nTopic: Nutritional and renal status\n\n[Context 23]\nContent: On 2017-04-16, Mr. John Chapman's medication regimen included Meropenem (Merrem) 4 g administered every 4 hours.\nTime: 2017-04-16T00:00:00\nPersons: John Chapman\nRelated Entities: Merrem\nTopic: Current medication\n\n[Context 24]\nContent: Current recommendations for Mr. John Chapman include careful balancing.\nPersons: John Chapman\nTopic: Clinical management recommendation\n\n[Context 25]\nContent: During preoperative assessment on 2018-08-08, Bagolini test results for Mr. John Chapman showed suppression at both distance and near fixation.\nTime: 2018-08-08T00:00:00\nLocation: Outpatient Clinic\nPersons: John Chapman\nTopic: Binocular vision testing\n\nQuestion:\nWhich sedative was Mr. Chapman on during the weaning process?\n\nOptions:\nA. Midazolam\nB. Propofol\nC. Clonidine\nD. Lorazepam\nE. Dexmedetomidine\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804983,
+      "id": "chatcmpl-05df697a-85ce-9346-b868-bf42e5724efc",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1873,
+        "total_tokens": 1877
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c5da8a615686a0b1.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c5da8a615686a0b1",
+  "timestamp": "2026-04-10T07:11:26.038768+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_20",
+    "question_id": 19,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Esophagogastroduodenoscopy performed on Mrs. Hilary Sanders, born on 1976-08-24, on 2023-04-01 revealed erythematous antral gastritis and an approximately 1 cm irregular mucosal area at the corpus-antrum junction on the greater curvature side.\nTime: 2023-04-01T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Upper endoscopy findings\n\n[Context 2]\nContent: External upper gastrointestinal endoscopy and colonoscopy are recommended for Mrs. Hilary Sanders, with a request to return with findings.\nPersons: Mrs. Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 3]\nContent: An external upper gastrointestinal endoscopy and colonoscopy were recommended for Mrs. Hilary Sanders as of 2018-04-12, with a request to return with findings.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 4]\nContent: Multiple glandular cysts less than 8 mm in size were observed in the fundus and corpus of the stomach of Mrs. Hilary Sanders, born on 1976-08-24, during esophagogastroduodenoscopy on 2023-04-01.\nTime: 2023-04-01T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastric cyst findings\n\n[Context 5]\nContent: A current gastroscopy was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Gastrointestinal diagnostic recommendation\n\n[Context 6]\nContent: Outpatient endoscopic diagnostics were recommended for Mrs. Hilary Sanders as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Diagnostic procedure recommendation\n\n[Context 7]\nContent: Capsule endoscopy performed on Mrs. Hilary Sanders, born on 1976-08-24, was incomplete but showed no evidence of inflammatory changes; some hyperemia and blurry vascular pattern were observed in the visible colon.\nPersons: Mrs. Hilary Sanders\nTopic: Capsule endoscopy findings\n\n[Context 8]\nContent: Outpatient endoscopic diagnostics were recommended for Mrs. Hilary Sanders as of 2018-04-12 to investigate persistent diarrhea.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Diagnostic recommendation\n\n[Context 9]\nContent: Mrs. Hilary Sanders was recommended to undergo external upper gastrointestinal endoscopy and colonoscopy, with a request to return with findings, as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal diagnostic recommendation\n\n[Context 10]\nContent: On 2020-04-14, referral to Gastroenterology was recommended for Mrs. Hilary Sanders due to persistent abdominal symptoms.\nTime: 2020-04-14T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Specialist referral\n\n[Context 11]\nContent: As of 2018-02-10, gastroscopy approximately every 2-3 years, depending on previous findings and Helicobacter pylori testing, was recommended for Mrs. Hilary Sanders.\nTime: 2018-02-10\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 12]\nContent: Follow-up in the gastroenterological outpatient clinic was recommended for Mrs. Hilary Sanders, born on 1976-08-24, after discharge on 2023-04-05.\nTime: 2023-04-05T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Post-discharge care recommendation\n\n[Context 13]\nContent: Consultation with Gastroenterology is recommended for Mrs. Hilary Sanders.\nPersons: Mrs. Hilary Sanders\nTopic: Specialist consultation\n\n[Context 14]\nContent: Gastroscopy approximately every 2-3 years, depending on previous findings and Helicobacter pylori testing, was recommended for Mrs. Hilary Sanders as of 2018-04-12.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 15]\nContent: Gastroscopy approximately every 2-3 years, depending on previous findings or H. pylori testing, was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Endoscopic surveillance recommendation\n\n[Context 16]\nContent: The CT scan on 03/04/2017 showed normal trachea and esophagus appearance and no evidence of hiatus hernia.\nTime: 2017-03-04T00:00:00\nTopic: Upper GI and airway CT findings\n\n[Context 17]\nContent: On 2017-10-06, Mrs. Hilary Sanders underwent an abdominal ultrasound showing a morphologically unremarkable pancreas with no space-occupying processes visible despite intestinal gas overlay.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Abdominal imaging finding\n\n[Context 18]\nContent: Mrs. Hilary Sanders was recommended to have gastroscopy approximately every 2-3 years depending on previous findings and Helicobacter pylori testing results, as of 2019-02-18.\nTime: 2019-02-18T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Periodic gastroscopy recommendation\n\n[Context 19]\nContent: As of 2020-02-12, Mrs. Hilary Sanders had adapted to her gastrointestinal issues and had an appointment scheduled with the Gastroenterology department.\nTime: 2020-02-12T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal symptom management\n\n[Context 20]\nContent: As of 2020-02-12, Mrs. Hilary Sanders had not had a gastroscopy or colonoscopy for some time.\nTime: 2020-02-12T00:00:00\nPersons: Mrs. Hilary Sanders\nTopic: Gastrointestinal endoscopy status\n\n[Context 21]\nContent: On 2017-10-06, Mrs. Hilary Sanders underwent an abdominal ultrasound showing a gallbladder and biliary tract without calculi, inflammation, or congestion.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Abdominal imaging finding\n\n[Context 22]\nContent: Annual H. pylori testing via breath test or stool antigen was recommended for Mrs. Hilary Sanders as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Hilary Sanders\nTopic: Gastrointestinal infection screening recommendation\n\n[Context 23]\nContent: Annual Helicobacter pylori testing via breath test or stool antigen test was recommended for Mrs. Hilary Sanders as of 2018-04-12.\nTime: 2018-04-12T00:00:00\nPersons: Hilary Sanders\nTopic: Infectious disease screening\n\n[Context 24]\nContent: As of 2018-02-10, Mrs. Hilary Sanders experienced ongoing diarrhea in the morning, often recurring in the afternoon, with no melena and no fresh blood.\nTime: 2018-02-10\nPersons: Hilary Sanders\nTopic: Gastrointestinal symptom description\n\n[Context 25]\nContent: Mrs. Hilary Sanders was instructed to report any unexpected side effects or changes in her condition immediately after the 2016-10-09 consultation.\nTime: 2016-10-09T00:00:00\nPersons: Hilary Sanders\nTopic: Patient safety instructions\n\nQuestion:\nWhich of the following findings were noted in Mrs. Sanders' esophagogastroduodenoscopy (EGD) report from 04/01/2023?\n\nOptions:\nA. Unremarkable mucosa in the bulb and descending part of the duodenum.\nB. Evidence of a hiatal hernia at the Z-line.\nC. Multiple peptic ulcers in the fundus and corpus.\nD. Irregular mucosal area in the distal esophagus.\nE. Significant mucosal erosion in the upper esophageal sphincter.\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: A",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: A",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775805085,
+      "id": "chatcmpl-6dfd09cf-5ad7-965a-a928-6920ca15febe",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2263,
+        "total_tokens": 2267
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c73dac63c3cc12b9.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c73dac63c3cc12b9",
+  "timestamp": "2026-04-10T07:06:56.589778+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_09",
+    "question_id": 13,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Paul Wells initiated treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy initiation\n\n[Context 2]\nContent: Paul Wells started treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Initiation of immunotherapy\n\n[Context 3]\nContent: After comprehensive counseling, Paul Wells commenced treatment with Atezolizumab and Bevacizumab on 2019-08-24.\nTime: 2019-08-24\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Informed consent and treatment start\n\n[Context 4]\nContent: Paul Wells was hospitalized in October 2019 for severe pneumonic sepsis before the next planned administration of Atezolizumab/Bevacizumab.\nTime: 2019-10-01T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Hospitalization due to infection\n\n[Context 5]\nContent: Atezolizumab/Bevacizumab was re-administered to Paul Wells after a prior pause.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Resumption of systemic therapy\n\n[Context 6]\nContent: Atezolizumab and Bevacizumab were re-administered to Paul Wells on 2022-01-25 and 2022-02-16, followed by another treatment pause due to limited tolerance.\nTime: 2022-01-25\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Re-initiation and discontinuation of immunotherapy\n\n[Context 7]\nContent: Paul Wells received re-administration of Atezolizumab and Bevacizumab on 2020-01-23 and 2020-02-14.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy re-initiation\n\n[Context 8]\nContent: Paul Wells received Atezolizumab/Bevacizumab treatment starting on 2021-10-26, with a pause initiated on 2019-09-17 due to transaminase elevation.\nTime: 2021-10-26T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy administration and interruption\n\n[Context 9]\nContent: Due to poor tolerance, Atezolizumab/Bevacizumab therapy was paused after 2020-02-14 in Paul Wells.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Discontinuation of systemic therapy\n\n[Context 10]\nContent: Paul Wells received re-administration of Atezolizumab and Bevacizumab on 2022-01-25 and 2022-02-16, followed by a treatment pause due to limited tolerance.\nTime: 2022-02-16T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Systemic therapy re-administration and discontinuation\n\n[Context 11]\nContent: After Atezolizumab/Bevacizumab administration on 2020-02-14, Paul Wells experienced significant side effects including oral burning, appetite and weight loss, low blood pressure, and worsening pulmonary status.\nTime: 2020-02-14T00:00:00\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Adverse effects of immunotherapy\n\n[Context 12]\nContent: Paul Wells experienced transient worsening of lung function requiring steroid treatment after administrations of Atezolizumab and Bevacizumab.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Pulmonary side effect of immunotherapy\n\n[Context 13]\nContent: Steroid treatment improved Paul Wells' pulmonary situation after Atezolizumab/Bevacizumab-related side effects.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Management of pulmonary adverse effects\n\n[Context 14]\nContent: Paul Wells paused Atezolizumab and Bevacizumab treatment starting on 2019-09-17 due to transaminase elevation up to 4 times the upper limit of normal.\nTime: 2019-09-17\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Treatment interruption due to liver toxicity\n\n[Context 15]\nContent: Paul Wells was extensively informed about systemic therapy options including Atezolizumab/Bevacizumab and alternative therapy with a tyrosine kinase inhibitor.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab, tyrosine kinase inhibitor\nTopic: Therapy options counseling\n\n[Context 16]\nContent: Paul Wells experienced transient worsening of lung function requiring steroid treatment after Atezolizumab/Bevacizumab administrations.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Pulmonary adverse reaction to immunotherapy\n\n[Context 17]\nContent: Paul Wells experienced a substantial increase in transaminases (GPT 164 U/L, GOT 151 U/L) after one administration of Atezolizumab/Bevacizumab, suspected to be immunotherapy-induced hepatitis.\nPersons: Paul Wells\nRelated Entities: Atezolizumab, Bevacizumab\nTopic: Hepatotoxicity from immunotherapy\n\n[Context 18]\nContent: A CT scan in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Imaging-based tumor response assessment\n\n[Context 19]\nContent: Staging examinations in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Tumor staging result\n\n[Context 20]\nContent: A CT scan performed in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01\nPersons: Paul Wells\nTopic: Imaging response assessment\n\n[Context 21]\nContent: A computed tomography (CT) scan performed in January 2020 showed very good tumor response in Paul Wells.\nTime: 2020-01-01T00:00:00\nPersons: Paul Wells\nTopic: Imaging-based tumor response assessment\n\n[Context 22]\nContent: The Liver Tumor Board made a decision on 2019-08-18 to recommend systemic therapy for Paul Wells.\nTime: 2019-08-18T00:00:00\nPersons: Paul Wells\nRelated Entities: Liver Tumor Board\nTopic: Liver Tumor Board recommendation\n\nQuestion:\nWhen was Atezolizumab/Bevacizumab first administered to Mr. Wells?\n\nOptions:\nA. 07/27/2019\nB. 08/24/2019\nC. 01/25/2022\nD. 08/18/2019\nE. 10/26/2021\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804815,
+      "id": "chatcmpl-69b38365-4fa5-9451-a6be-6b6dcb767d92",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 2090,
+        "total_tokens": 2094
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c7545d8082ed65d3.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c7545d8082ed65d3",
+  "timestamp": "2026-04-10T07:03:39.407639+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_01",
+    "question_id": 11,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed no vertebral body collapse or deformity and normal bone marrow signal apart from known lesions.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Vertebral integrity findings\n\n[Context 2]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed reduced mass effect and decreased impingement on the myelon at T10-L1 levels.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal cord compression findings\n\n[Context 3]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed unremarkable conus medullaris and cauda equina nerve roots without displacement or compression.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Nerve root findings\n\n[Context 4]\nContent: Neurological examination of Mrs. Anna Sample on 2017-10-09 was stable with no new deficits.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Neurological assessment\n\n[Context 5]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed normal spinal canal caliber with no significant stenosis.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal canal findings\n\n[Context 6]\nContent: Liver MRI on 2017-10-11 for Mrs. Anna Sample showed a region in the anterolateral segment with T2 hyperintensity, T1 hypointensity, and restricted diffusion.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver lesion characteristics\n\n[Context 7]\nContent: A PET scan performed on 2017-10-09 for Mrs. Anna Sample showed a favorable response but increased FDG avidity in the liver, prompting recommendation for liver MRI.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: PET scan findings and recommendations\n\n[Context 8]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed preserved hydration of intervertebral discs and no significant disc protrusions or herniations.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Disc integrity findings\n\n[Context 9]\nContent: Lesions at L2, L3, and L4 levels in Mrs. Anna Sample showed signs of regression on MRI as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal lesion regression\n\n[Context 10]\nContent: Physical examination of Mrs. Anna Sample on 2017-10-09 revealed no palpable lymphadenopathy.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Physical examination result\n\n[Context 11]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed no FDG uptake in the spine, including previously described metastatic lesion.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Bone PET findings\n\n[Context 12]\nContent: Bone marrow aspiration in Mrs. Anna Sample revealed no infiltration by lymphoma.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Bone marrow evaluation for lymphoma\n\n[Context 13]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed regression of lesions at L2, L3, and L4 levels in both size and intensity.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Lumbar spine lesion regression\n\n[Context 14]\nContent: A CT scan of the chest, abdomen, and pelvis performed on 2016-12-24 in Mrs. Anna Sample showed an enlarged left axillary lymph node.\nTime: 2016-12-24\nPersons: Anna Sample\nTopic: Lymph node imaging finding\n\n[Context 15]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed reduction in size of previously noted metastatic masses compared to prior studies.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal MRI findings\n\n[Context 16]\nContent: Cerebrospinal fluid analysis in Mrs. Anna Sample showed no evidence of malignancy.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: CSF analysis for lymphoma involvement\n\n[Context 17]\nContent: Mrs. Sample denied respiratory symptoms, infections, systemic symptoms, or gastrointestinal complaints.\nPersons: Mrs. Sample\nTopic: Absence of systemic or organ-specific symptoms\n\n[Context 18]\nContent: On 2016-12-21, Mrs. Sample underwent surgical decompression at DC, which resulted in symptom relief.\nTime: 2016-12-21T00:00:00\nLocation: DC\nPersons: Mrs. Sample\nTopic: Surgical intervention for spinal compression\n\n[Context 19]\nContent: Liver MRI conducted on 2017-10-11 for Mrs. Anna Sample showed no pathology of the liver.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver imaging result\n\n[Context 20]\nContent: A cranial MRI performed on Mrs. Anna Sample showed chronic inflammatory lesions suggestive of Multiple Sclerosis.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Neuroimaging findings suggestive of MS\n\n[Context 21]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed no pathological FDG uptake in the previously noted left axillary lymph node.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Lymph node PET findings\n\n[Context 22]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed increased FDG uptake in the liver anterolateral segment with SUV max 5.5.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Liver PET findings\n\n[Context 23]\nContent: A cranial MRI performed on 2016-12-19 in Mrs. Anna Sample showed chronic inflammatory marks indicative of Multiple Sclerosis.\nTime: 2016-12-19\nPersons: Anna Sample\nTopic: Neuroimaging supporting MS diagnosis\n\n[Context 24]\nContent: Ultrasound of the abdomen for Mrs. Anna Sample was performed on 2017-10-05.\nTime: 2017-10-05T00:00:00\nPersons: Anna Sample\nTopic: Diagnostic imaging procedure\n\n[Context 25]\nContent: On 2016-12-19, Mrs. Sample presented with acute upper limb pain and restricted mobility in the context of pre-existing ALS.\nTime: 2016-12-19T00:00:00\nPersons: Mrs. Sample\nTopic: Symptom onset related to ALS and spinal pathology\n\nQuestion:\nMrs. Sample underwent multiple imaging examinations. Which body part could not be assessed in these examinations?\n\nOptions:\nA. Liver\nB. Lungs\nC. Thyroid\nD. Uterus\nE. Feet\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804618,
+      "id": "chatcmpl-d0d1fff3-8ccb-92bc-a832-9f8a9db5bcf5",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1983,
+        "total_tokens": 1987
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c772837eb20182de.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c772837eb20182de",
+  "timestamp": "2026-04-10T06:57:17.249615+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which is the best reflection of the chronological order of radiology imaging examinations in Mr. Davies?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"radiology\", \"imaging examinations\", \"chronological order\"],\n  \"persons\": [\"Mr. Davies\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"radiology\", \"imaging examinations\", \"chronological order\"],\n  \"persons\": [\"Mr. Davies\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804235,
+      "id": "chatcmpl-fc40a6d4-d95c-990e-9745-3c5f394adc66",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 51,
+        "prompt_tokens": 190,
+        "total_tokens": 241
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c7cda36d1379b125.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c7cda36d1379b125",
+  "timestamp": "2026-04-10T06:51:15.103101+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which immunotherapy was Mr. Rudolph administered from May to September 2020?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"immunotherapy\", \"administered\"],\n  \"persons\": [\"Mr. Rudolph\"],\n  \"time_expression\": \"May to September 2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"immunotherapy\", \"administered\"],\n  \"persons\": [\"Mr. Rudolph\"],\n  \"time_expression\": \"May to September 2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803872,
+      "id": "chatcmpl-b846c2d2-cf72-9e6a-a68f-11a014da1de9",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 56,
+        "prompt_tokens": 190,
+        "total_tokens": 246
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c84ee01ca7e28c3d.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c84ee01ca7e28c3d",
+  "timestamp": "2026-04-10T06:57:13.962061+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Comparing the lab results, how did Mr. Davies' creatinine levels change from August 2016 to June 2019?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"lab results\", \"creatinine levels\", \"change\"],\n  \"persons\": [\"Mr. Davies\"],\n  \"time_expression\": \"from August 2016 to June 2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"lab results\", \"creatinine levels\", \"change\"],\n  \"persons\": [\"Mr. Davies\"],\n  \"time_expression\": \"from August 2016 to June 2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804231,
+      "id": "chatcmpl-8ee7fcea-b4e1-9ccc-bc3f-68fb84b93050",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 64,
+        "prompt_tokens": 202,
+        "total_tokens": 266
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c878a08d4e977875.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c878a08d4e977875",
+  "timestamp": "2026-04-10T07:05:29.628148+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_06",
+    "question_id": 5,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: The final resection specimen from Mr. Paul Doe's surgery histologically confirmed a 2.9 cm squamous cell carcinoma consistent with metastatic recurrence of previously known hypopharyngeal carcinoma.\nPersons: Paul Doe\nTopic: Histopathological findings\n\n[Context 2]\nContent: Histological analysis of the resected specimen from Mr. Paul Doe confirmed a 2.9 cm squamous cell carcinoma consistent with metastatic recurrence of previously known hypopharyngeal carcinoma.\nPersons: Paul Doe\nTopic: Histopathological diagnosis of metastasis\n\n[Context 3]\nContent: Mr. Paul Doe was diagnosed with metachronous pulmonary metastatic squamous cell carcinoma at the base of the tongue.\nPersons: Paul Doe\nTopic: Cancer diagnosis\n\n[Context 4]\nContent: Mr. Paul Doe presented for postoperative follow-up after left-sided videothoracoscopic upper lobe resection due to previously diagnosed pulmonary metastatic hypopharyngeal carcinoma.\nPersons: Paul Doe\nTopic: Post-surgical follow-up\n\n[Context 5]\nContent: Mr. Paul Doe's recurrent oropharyngeal carcinoma was staged as rpT2 rpN2(2/24, ECE -) L1 V0 Pn0 G2 R0.\nPersons: Paul Doe\nTopic: Cancer staging details\n\n[Context 6]\nContent: Histological examination of the resection specimen from Mr. Paul Doe's 2022-01-11 surgery confirmed a 2.9 cm solid carcinoma consistent with metastasis from previously diagnosed squamous cell carcinoma.\nTime: 2022-01-11T00:00:00\nPersons: Paul Doe\nTopic: Pathology findings\n\n[Context 7]\nContent: Mr. Paul Doe was diagnosed with metachronous pulmonary metastatic squamous cell carcinoma.\nPersons: Paul Doe\nTopic: Cancer diagnosis\n\n[Context 8]\nContent: Mr. Paul Doe had a previous diagnosis of recurrent oropharyngeal carcinoma with ICD-10 code C01.\nPersons: Paul Doe\nTopic: Previous cancer diagnosis\n\n[Context 9]\nContent: The MR neck scan of Mr. Paul Doe on 2021-09-24 showed known status post tumor resection with laryngectomy for extensive recurrence of oropharyngeal carcinoma, follow-up after radiotherapy, somewhat increasing swelling from nasopharynx to oropharynx, stable swelling from the uvula, no clear recurrence-specific tissue proliferation or contrast uptake, unchanged accentuated lymph nodes in level Ib/IIa on the left with one borderline large lymph node similar to prior exam, minimally displaced mastoid cells on the left, and moderate degenerative changes of the cervical spine.\nTime: 2021-09-24T00:00:00\nPersons: Paul Doe\nTopic: Radiology findings\n\n[Context 10]\nContent: The histology report for Mr. Paul Doe described a 2.9 cm solid carcinoma in the resected left upper lobe, consistent with metastasis from previously diagnosed non-keratinizing squamous cell carcinoma.\nPersons: Paul Doe\nTopic: Detailed histopathological findings\n\n[Context 11]\nContent: The bone of the left lateral thigh of the hyoid in Mr. Paul Doe was carcinoma-free.\nPersons: Paul Doe\nTopic: Bone involvement\n\n[Context 12]\nContent: Histology of Mr. Paul Doe revealed invasive, moderately differentiated, squamous cell carcinoma with keratinization at the medial left base of the tongue, with maximum extent of 1.0 cm.\nPersons: Paul Doe\nTopic: Pathological diagnosis\n\n[Context 13]\nContent: Mr. Paul Doe underwent panendoscopy, biopsy, and received an initial diagnosis of left tongue base carcinoma on 2014-05-14.\nTime: 2014-05-14\nPersons: Paul Doe\nTopic: Diagnostic procedure and initial cancer diagnosis\n\n[Context 14]\nContent: Focal vascular invasions were observed in the histological specimen from Mr. Paul Doe, but no pleural invasion was noted.\nPersons: Paul Doe\nTopic: Histopathological invasion details\n\n[Context 15]\nContent: Mr. Paul Doe was diagnosed with pT1, pN0 (0/21, ECE negative), cM0, Pn0, G2, RX, L0, V0, left midline tongue carcinoma.\nPersons: Paul Doe\nTopic: Oncological diagnosis\n\n[Context 16]\nContent: Mr. Paul Doe underwent surgical resection via lateral pharyngotomy and neck dissection for tongue base carcinoma.\nPersons: Paul Doe\nTopic: Surgical treatment details\n\n[Context 17]\nContent: Mr. Paul Doe initially presented with pT1, pN0 (0/21, ECE negative), cM0, Pn0, G2, RX, L0, V0, left midline tongue carcinoma.\nPersons: Paul Doe\nTopic: Initial cancer presentation and staging\n\n[Context 18]\nContent: Frozen section analysis of medial resection of the tongue base in Mr. Paul Doe confirmed squamous cell carcinoma.\nPersons: Paul Doe\nTopic: Intraoperative cancer confirmation\n\n[Context 19]\nContent: A follow-up CT examination identified a suspicious lung lesion in Mr. Paul Doe, raising concern for metastasis from previously diagnosed left midline tongue carcinoma (pT1, pN0, G2, RX).\nPersons: Paul Doe\nTopic: Metastasis suspicion based on imaging\n\n[Context 20]\nContent: Histology confirmed squamous cell carcinoma in Mr. Paul Doe after surgical resection.\nPersons: Paul Doe\nTopic: Histopathological confirmation\n\n[Context 21]\nContent: Mr. Paul Doe received radiotherapy following surgical resection of tongue base carcinoma.\nPersons: Paul Doe\nTopic: Adjuvant cancer therapy\n\n[Context 22]\nContent: Mr. Paul Doe has hypothyroidism.\nPersons: Paul Doe\nTopic: Endocrine disorder\n\n[Context 23]\nContent: Mr. Paul Doe was born on 1965-08-08.\nTime: 1965-08-08T00:00:00\nPersons: Paul Doe\nTopic: Patient demographic information\n\n[Context 24]\nContent: Mr. Paul Doe was treated in the clinic from 2014-05-28 to 2014-06-20.\nTime: 2014-05-28T00:00:00\nPersons: Paul Doe\nTopic: Treatment period\n\n[Context 25]\nContent: Mr. Paul Doe underwent liver surgery in 2013.\nTime: 2013-01-01T00:00:00\nPersons: Paul Doe\nTopic: Past surgical history\n\nQuestion:\nRegarding Paul Doe, what was the histological size of the metastatic recurrence from the previously known hypopharyngeal carcinoma?\n\nOptions:\nA. 1.9 cm\nB. 3.9 cm\nC. 2.4 cm\nD. 2.9 cm\nE. 2.2 cm\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: D",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: D",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804727,
+      "id": "chatcmpl-da69ef6e-c9ee-919e-81ad-11eb89701278",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1665,
+        "total_tokens": 1669
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c92064280d7b8fab.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c92064280d7b8fab",
+  "timestamp": "2026-04-10T06:55:01.114585+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Regarding Mr. Harder, what was the correct chronological order of radiological and nuclear medicine imaging studies?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"Mr. Harder\", \"radiological\", \"nuclear medicine\", \"imaging studies\", \"chronological order\"],\n  \"persons\": [\"Mr. Harder\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"Mr. Harder\", \"radiological\", \"nuclear medicine\", \"imaging studies\", \"chronological order\"],\n  \"persons\": [\"Mr. Harder\"],\n  \"time_expression\": null,\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804097,
+      "id": "chatcmpl-229a26c7-caa5-9ec0-b949-10ea71280174",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 63,
+        "prompt_tokens": 192,
+        "total_tokens": 255
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c9696f760afa1010.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_c9696f760afa1010",
+  "timestamp": "2026-04-10T07:03:26.108356+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_01",
+    "question_id": 1,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mrs. Sample denied respiratory symptoms, infections, systemic symptoms, or gastrointestinal complaints.\nPersons: Mrs. Sample\nTopic: Absence of systemic or organ-specific symptoms\n\n[Context 2]\nContent: Neurological examination of Mrs. Anna Sample on 2017-10-09 was stable with no new deficits.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Neurological assessment\n\n[Context 3]\nContent: Laboratory findings for Mrs. Anna Sample as of 2017-10-09 showed blood counts and biochemistry panels trending toward normalization, with liver enzymes within reference range.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Laboratory test results\n\n[Context 4]\nContent: Physical examination of Mrs. Anna Sample on 2017-10-09 revealed no palpable lymphadenopathy.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Physical examination result\n\n[Context 5]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed no vertebral body collapse or deformity and normal bone marrow signal apart from known lesions.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Vertebral integrity findings\n\n[Context 6]\nContent: Inflammatory markers for Mrs. Anna Sample showed CRP 1.8 mg/dL above reference range <0.5 mg/dL.\nPersons: Anna Sample\nTopic: Inflammation test result\n\n[Context 7]\nContent: Liver MRI on 2017-10-11 for Mrs. Anna Sample showed a region in the anterolateral segment with T2 hyperintensity, T1 hypointensity, and restricted diffusion.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver lesion characteristics\n\n[Context 8]\nContent: Mrs. Sample had a urinary catheter in place at the time of documentation.\nPersons: Mrs. Sample\nTopic: Urinary catheter status\n\n[Context 9]\nContent: Cerebrospinal fluid analysis in Mrs. Anna Sample showed no evidence of malignancy.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: CSF analysis for lymphoma involvement\n\n[Context 10]\nContent: Liver MRI conducted on 2017-10-11 for Mrs. Anna Sample showed no pathology of the liver.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver imaging result\n\n[Context 11]\nContent: Liver MRI on 2017-10-11 for Mrs. Anna Sample confirmed liver enlargement consistent with prior ultrasound measurements.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver size confirmation\n\n[Context 12]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed increased FDG uptake in the liver anterolateral segment with SUV max 5.5.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Liver PET findings\n\n[Context 13]\nContent: A PET scan performed on 2017-10-09 for Mrs. Anna Sample showed a favorable response but increased FDG avidity in the liver, prompting recommendation for liver MRI.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: PET scan findings and recommendations\n\n[Context 14]\nContent: Liver MRI on 2017-10-11 for Mrs. Anna Sample showed peripheral enhancement in arterial phase with progressive central filling, suggestive of focal nodular hyperplasia or atypical hemangioma.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver lesion enhancement pattern\n\n[Context 15]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed reduction in size of previously noted metastatic masses compared to prior studies.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal MRI findings\n\n[Context 16]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed normal spinal canal caliber with no significant stenosis.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal canal findings\n\n[Context 17]\nContent: MRI on 2017-10-06 for Mrs. Anna Sample showed preserved hydration of intervertebral discs and no significant disc protrusions or herniations.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Disc integrity findings\n\n[Context 18]\nContent: PET/CT on 2017-10-09 for Mrs. Anna Sample showed no FDG uptake in the spine, including previously described metastatic lesion.\nTime: 2017-10-09T00:00:00\nPersons: Anna Sample\nTopic: Bone PET findings\n\n[Context 19]\nContent: Bone marrow aspiration in Mrs. Anna Sample revealed no infiltration by lymphoma.\nTime: 2017-01-01\nPersons: Anna Sample\nTopic: Bone marrow evaluation for lymphoma\n\n[Context 20]\nContent: Lesions at L2, L3, and L4 levels in Mrs. Anna Sample showed signs of regression on MRI as of 2017-10-06.\nTime: 2017-10-06T00:00:00\nPersons: Anna Sample\nTopic: Spinal lesion regression\n\n[Context 21]\nContent: Impression of liver MRI on 2017-10-11 for Mrs. Anna Sample indicated enlarged liver with lesion consistent with focal nodular hyperplasia or atypical hemangioma and no lymphomatous involvement.\nTime: 2017-10-11T00:00:00\nPersons: Anna Sample\nTopic: Liver MRI clinical impression\n\n[Context 22]\nContent: Mrs. Sample reported a weight loss of 5 kg during her hospitalization.\nPersons: Mrs. Sample\nTopic: Weight change during hospital stay\n\n[Context 23]\nContent: On 2016-12-21, Mrs. Sample underwent surgical decompression at DC, which resulted in symptom relief.\nTime: 2016-12-21T00:00:00\nLocation: DC\nPersons: Mrs. Sample\nTopic: Surgical intervention for spinal compression\n\n[Context 24]\nContent: At the time of documentation, Mrs. Sample reported post-operative spine discomfort, shoulder hypoesthesia, and intermittent hand numbness.\nPersons: Mrs. Sample\nTopic: Post-surgical neurological symptoms\n\n[Context 25]\nContent: On 2016-12-19, Mrs. Sample presented with acute upper limb pain and restricted mobility in the context of pre-existing ALS.\nTime: 2016-12-19T00:00:00\nPersons: Mrs. Sample\nTopic: Symptom onset related to ALS and spinal pathology\n\nQuestion:\nIn the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?\n\nOptions:\nA. She has 2-vessel disease\nB. She was diagnosed with primary progressive type of multiple sclerosis.\nC. She has a mood disorder.\nD. She has 3-vessel CHD.\nE. She has pre-existing ALS.\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: B",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: B",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804605,
+      "id": "chatcmpl-064d883d-ed10-9358-a943-9cfdb21b542b",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1922,
+        "total_tokens": 1926
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_c98dbe82fc6a5506.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_c98dbe82fc6a5506",
+  "timestamp": "2026-04-10T06:55:37.046818+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: After the initial MRI, what was the next step taken for Mr. Havers' treatment?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"MRI\", \"treatment\", \"next step\"],\n  \"persons\": [\"Mr. Havers\"],\n  \"time_expression\": \"After the initial MRI\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"MRI\", \"treatment\", \"next step\"],\n  \"persons\": [\"Mr. Havers\"],\n  \"time_expression\": \"After the initial MRI\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804134,
+      "id": "chatcmpl-ce6021e5-142a-9014-8a58-0b4c92bc6757",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 53,
+        "prompt_tokens": 190,
+        "total_tokens": 243
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ca1babccfbf5fd44.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_ca1babccfbf5fd44",
+  "timestamp": "2026-04-10T06:48:09.552409+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What imaging was performed on Laura Miller on 06/13/2020?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"imaging\", \"Laura Miller\", \"06/13/2020\"],\n  \"persons\": [\"Laura Miller\"],\n  \"time_expression\": \"06/13/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"imaging\", \"Laura Miller\", \"06/13/2020\"],\n  \"persons\": [\"Laura Miller\"],\n  \"time_expression\": \"06/13/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803686,
+      "id": "chatcmpl-023967ee-ad95-95db-94f8-9a45de2548f3",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 66,
+        "prompt_tokens": 191,
+        "total_tokens": 257
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ca4bcd774dbeb99d.json

@@ -0,0 +1,53 @@
+{
+  "trace_id": "llm_trace_ca4bcd774dbeb99d",
+  "timestamp": "2026-04-10T07:08:01.440787+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "component": "qa_answerer",
+    "operation": "simplemem_rebuild_mcq",
+    "patient_id": "patient_12",
+    "question_id": 5,
+    "attempt": 1,
+    "llm_request": {
+      "request_name": "answer.simplemem_mcq",
+      "max_tokens_option": 1200,
+      "max_tokens_sent": true,
+      "max_tokens": 1200
+    }
+  },
+  "request": {
+    "system_prompt": "You answer multiple-choice questions from memory context and follow output format strictly.",
+    "user_prompt": "You are answering a medical-memory multiple-choice question using only the retrieved memory context.\n\nRetrieved Context:\n[Context 1]\nContent: Mr. Alan Fisher underwent a complication-free renal transplant biopsy on 2009-04-19.\nTime: 2009-04-19T00:00:00\nPersons: Alan Fisher\nTopic: Biopsy procedure\n\n[Context 2]\nContent: The renal transplant biopsy of Mr. Alan Fisher on 2009-04-19 showed isometric tubular epithelial vacuolization without significant inflammation or scarring.\nTime: 2009-04-19T00:00:00\nPersons: Alan Fisher\nTopic: Biopsy pathological findings\n\n[Context 3]\nContent: Mr. Alan Fisher has been on dual immunosuppression therapy with Cyclosporin A and steroids since October 1995 following renal transplantation.\nTime: 1995-10-01\nPersons: Alan Fisher\nTopic: Long-term immunosuppressive therapy\n\n[Context 4]\nContent: Mr. Alan Fisher was admitted for renal transplant biopsy due to progressive deterioration of transplant function with creatinine rising from approximately 1.1 mg/dL to 1.4–1.6 mg/dL.\nPersons: Alan Fisher\nTopic: Reason for hospital admission\n\n[Context 5]\nContent: Ultrasound of Mr. Alan Fisher's transplant kidney on 2009-04-20 showed a well-visualized kidney in the left iliac fossa with normal parenchymal echogenicity, normal corticomedullary differentiation, and no hematoma or arteriovenous fistula post-biopsy.\nTime: 2009-04-20T00:00:00\nPersons: Alan Fisher\nTopic: Renal transplant imaging\n\n[Context 6]\nContent: Mr. Alan Fisher underwent renal transplantation on 1995-10-25.\nTime: 1995-10-25T00:00:00\nPersons: Alan Fisher\nTopic: Transplant surgery history\n\n[Context 7]\nContent: The transplant kidney of Mr. Alan Fisher appeared non-dilated and well-perfused.\nPersons: Alan Fisher\nTopic: Transplant kidney imaging\n\n[Context 8]\nContent: Mr. Alan Fisher has progressive deterioration of renal transplant function without evidence of biopsy-proven rejection.\nPersons: Alan Fisher\nTopic: Primary renal diagnosis\n\n[Context 9]\nContent: During his hospitalization from 2018-04-11 to 2018-12-11, Mr. Alan Fisher's ciclosporin levels remained within the target range.\nPersons: Alan Fisher\nTopic: Immunosuppressant level monitoring\n\n[Context 10]\nContent: Ciclosporin level monitoring was recommended for Mr. Alan Fisher.\nPersons: Alan Fisher\nRelated Entities: Ciclosporin\nTopic: Medication monitoring recommendation\n\n[Context 11]\nContent: Laboratory tests of Mr. Alan Fisher revealed acute kidney transplant failure with creatinine increasing from 1.56 mg/dL to 2.35 mg/dL during his hospitalization from 2018-04-11 to 2018-12-11.\nPersons: Alan Fisher\nTopic: Renal laboratory findings\n\n[Context 12]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's medication regimen included Mycophenolic Acid (Myfortic) 385 mg twice daily in the morning and evening.\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nRelated Entities: Mycophenolic Acid, Myfortic\nTopic: Discharge medication\n\n[Context 13]\nContent: Mr. Alan Fisher has been on dual immunosuppression with Cyclosporin A and Steroid since October 1995.\nTime: 1995-10-01T00:00:00\nPersons: Alan Fisher\nTopic: Immunosuppressive therapy history\n\n[Context 14]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's medication regimen included Cyclosporine, microemulsified (Neoral) 50 mg twice daily in the morning and evening.\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nRelated Entities: Cyclosporine, Neoral\nTopic: Discharge medication\n\n[Context 15]\nContent: At discharge on 2020-03-19, Mr. Alan Fisher's medication regimen included Cyclosporine, microemulsified (Neoral) 10 mg twice daily in the morning and evening.\nTime: 2020-03-19T00:00:00\nPersons: Alan Fisher\nRelated Entities: Cyclosporine, Neoral\nTopic: Discharge medication\n\n[Context 16]\nContent: At discharge, Mr. Alan Fisher's medication regimen included Mycophenolic Acid (Myfortic) 360 mg once in the morning and once in the evening.\nPersons: Alan Fisher\nRelated Entities: Mycophenolic Acid, Myfortic\nTopic: Discharge medication\n\n[Context 17]\nContent: Mr. Alan Fisher has a history of renal transplantation performed on 1995-10-25.\nTime: 1995-10-25\nPersons: Alan Fisher\nTopic: Renal transplant history\n\n[Context 18]\nContent: Mr. Alan Fisher's immunosuppressive therapy was adjusted by modifying Cyclosporin-A levels and adding a lymphocyte proliferation inhibitor to existing dual therapy.\nPersons: Alan Fisher\nTopic: Immunosuppression regimen modification\n\nQuestion:\nWhat medication was added to Mr. Fisher's therapy following the kidney transplant biopsy in April 2009?\n\nOptions:\nA. Cyclosporine A\nB. Steroid\nC. Lymphocyte proliferation inhibitor\nD. Marcumar\nE. Minoxidil\n\nInstructions:\n1. Use only the retrieved context above.\n2. Choose exactly one option letter.\n3. Output exactly one line in this format: Final answer: <LETTER>\n4. <LETTER> must be one of: A, B, C, D, E\n5. Do not output any additional text."
+  },
+  "response": {
+    "text": "Final answer: C",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "Final answer: C",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775804880,
+      "id": "chatcmpl-95f85880-c770-99c2-a5a5-9b009abea197",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 4,
+        "prompt_tokens": 1460,
+        "total_tokens": 1464
+      },
+      "_request_meta": {
+        "request_name": "answer.simplemem_mcq",
+        "max_tokens_sent": true,
+        "max_tokens": 1200
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ca5be4a5f247d248.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_ca5be4a5f247d248",
+  "timestamp": "2026-04-10T06:49:38.448016+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: As of 11/20/2020, which COPD severity level was Mr. Wells classified under?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"COPD\", \"severity level\", \"classified\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"11/20/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"COPD\", \"severity level\", \"classified\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"11/20/2020\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803775,
+      "id": "chatcmpl-9fa45adf-916c-9550-9907-ef78fd01e13d",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 59,
+        "prompt_tokens": 197,
+        "total_tokens": 256
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_ca68ee3acceb81b1.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_ca68ee3acceb81b1",
+  "timestamp": "2026-04-10T06:53:00.175848+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: What was a notable finding in Mr. Fisher's kidney biopsy on 04/19/2009?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"notable finding\", \"kidney biopsy\"],\n  \"persons\": [\"Mr. Fisher\"],\n  \"time_expression\": \"04/19/2009\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"notable finding\", \"kidney biopsy\"],\n  \"persons\": [\"Mr. Fisher\"],\n  \"time_expression\": \"04/19/2009\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803977,
+      "id": "chatcmpl-2dc1c9a0-8c50-964e-ace5-6e1cc180b82a",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 57,
+        "prompt_tokens": 196,
+        "total_tokens": 253
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}

artifacts/longhealthmem/ablations/retrieval_reasoning/exp_qwen_benchmark_simple_t15000_ablate_retrieval_reasoning/logs/llm_outputs/llm_trace_cac779e7a4bc7b58.json

@@ -0,0 +1,48 @@
+{
+  "trace_id": "llm_trace_cac779e7a4bc7b58",
+  "timestamp": "2026-04-10T06:49:51.965687+00:00",
+  "provider": "qwen",
+  "model": "qwen3-max-2026-01-23",
+  "context": {
+    "llm_request": {
+      "request_name": "retrieval.analyze_query",
+      "max_tokens_option": 900,
+      "max_tokens_sent": true,
+      "max_tokens": 900
+    }
+  },
+  "request": {
+    "system_prompt": "You are a query analysis assistant. You must output valid JSON format.",
+    "user_prompt": "Analyze the following query and extract key information:\n\nQuery: Which diagnostic procedure was conducted first for Mr. Wells after his admission on 07/26/2019?\n\nPlease extract:\n1. keywords: List of keywords (names, places, topic words, etc.)\n2. persons: Person names mentioned\n3. time_expression: Time expression (if any)\n4. location: Location (if any)\n5. entities: Entities (companies, products, etc.)\n\nReturn in JSON format:\n```json\n{\n  \"keywords\": [\"keyword1\", \"keyword2\"],\n  \"persons\": [\"name1\", \"name2\"],\n  \"time_expression\": \"time expression or null\",\n  \"location\": \"location or null\",\n  \"entities\": [\"entity1\"]\n}\n```\n\nReturn ONLY JSON, no other content."
+  },
+  "response": {
+    "text": "```json\n{\n  \"keywords\": [\"diagnostic procedure\", \"admission\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"07/26/2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+    "raw_response": {
+      "choices": [
+        {
+          "finish_reason": "stop",
+          "index": 0,
+          "message": {
+            "content": "```json\n{\n  \"keywords\": [\"diagnostic procedure\", \"admission\"],\n  \"persons\": [\"Mr. Wells\"],\n  \"time_expression\": \"07/26/2019\",\n  \"location\": null,\n  \"entities\": []\n}\n```",
+            "role": "assistant"
+          }
+        }
+      ],
+      "created": 1775803789,
+      "id": "chatcmpl-5d87b2d6-da71-981f-883d-bc270c2aebc9",
+      "model": "qwen3-max-2026-01-23",
+      "object": "chat.completion",
+      "usage": {
+        "completion_tokens": 56,
+        "prompt_tokens": 197,
+        "total_tokens": 253
+      },
+      "_request_meta": {
+        "request_name": "retrieval.analyze_query",
+        "max_tokens_sent": true,
+        "max_tokens": 900
+      }
+    },
+    "error": null
+  }
+}